KR20220012859A - Cured film forming composition, alignment material and retardation material - Google Patents

Cured film forming composition, alignment material and retardation material Download PDF

Info

Publication number
KR20220012859A
KR20220012859A KR1020217038911A KR20217038911A KR20220012859A KR 20220012859 A KR20220012859 A KR 20220012859A KR 1020217038911 A KR1020217038911 A KR 1020217038911A KR 20217038911 A KR20217038911 A KR 20217038911A KR 20220012859 A KR20220012859 A KR 20220012859A
Authority
KR
South Korea
Prior art keywords
group
component
cured film
alignment
methyl
Prior art date
Application number
KR1020217038911A
Other languages
Korean (ko)
Inventor
나오야 니시무라
준 이토
Original Assignee
닛산 가가쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 닛산 가가쿠 가부시키가이샤 filed Critical 닛산 가가쿠 가부시키가이샤
Publication of KR20220012859A publication Critical patent/KR20220012859A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24Homopolymers or copolymers of amides or imides
    • C08L33/26Homopolymers or copolymers of acrylamide or methacrylamide
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/07Aldehydes; Ketones
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/22Compounds containing nitrogen bound to another nitrogen atom
    • C08K5/23Azo-compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24Homopolymers or copolymers of amides or imides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • G02B5/3083Birefringent or phase retarding elements
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • G02F1/13363Birefringent elements, e.g. for optical compensation
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00Polymer mixtures characterised by other features
    • C08L2205/02Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
    • C08L2205/025Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nonlinear Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Liquid Crystal (AREA)

Abstract

[과제] 우수한 배향감도를 가지며, 배향균일성도 우수함과 함께, 박막이어도 액정용액 중의 용제에 대한 내성을 가지고, 필름기판을 보호하는 보호층으로서도 기능할 수 있는 배향재와, 그것을 얻기 위한 경화막 형성 조성물을 제공한다.
[해결수단] 경화막 형성 조성물은, (A)광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는 화합물, (B)적어도 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머, 그리고 (C)적어도 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머를 함유하고, 필요에 따라 (D)성분으로서 가교촉매 및 (E)성분으로서 밀착향상성분을 추가로 함유한다. 이 경화막 형성 조성물을 이용하여, 경화막을 형성하고, 광배향기술을 이용하여 배향재를 형성한다. 배향재의 위에 중합성 액정을 도포하고, 경화시켜 위상차재를 얻는다.
[Problem] An alignment material that has excellent orientation sensitivity and excellent alignment uniformity, has resistance to solvents in liquid crystal solution even when it is a thin film, and can function as a protective layer to protect a film substrate, and a cured film for obtaining it A composition is provided.
[Solutions] The cured film forming composition is (A) a compound having one substituent selected from the group consisting of a photo-alignment group, a hydroxyl group, a carboxyl group and an amino group, (B) at least N-alkoxymethyl (meth)acrylamide A polymer formed by polymerizing a monomer containing a compound, and (C) a polymer formed by polymerizing a monomer containing at least an N-hydroxyalkyl (meth)acrylamide compound, and optionally a crosslinking catalyst as component (D) and (E) an adhesion improving component as a component. A cured film is formed using this cured film formation composition, and an orientation material is formed using the photo-alignment technique. A polymeric liquid crystal is apply|coated on the orientation material, it is made to harden|cure, and retardation material is obtained.

Description

경화막 형성 조성물, 배향재 및 위상차재Cured film forming composition, alignment material and retardation material

본 발명은, 경화막 형성 조성물, 배향재 및 위상차재에 관한 것이다.TECHNICAL FIELD This invention relates to a cured film formation composition, an orientation material, and retardation material.

원편광 안경방식의 3D디스플레이의 경우, 액정패널 등의 화상을 형성하는 표시소자의 위에 위상차재가 배치되는 것이 통상이다. 이 위상차재는, 위상차특성이 상이한 2종류의 위상차영역이 각각 복수, 규칙적으로 배치되어 있으며, 패터닝된 위상차재를 구성하고 있다. 한편, 이하, 본 명세서에 있어서는, 이러한 위상차특성이 상이한 복수의 위상차영역을 배치하도록 패턴화된 위상차재를 패턴화 위상차재라 칭한다.In the case of a circularly polarized glasses type 3D display, it is common that a phase difference material is disposed on a display element that forms an image such as a liquid crystal panel. In this phase difference material, two types of phase difference areas from which phase difference characteristics differ are respectively arrange|positioned regularly and plural, respectively, and comprises the patterned phase difference material. On the other hand, in the present specification, the phase difference material patterned so as to arrange a plurality of phase difference regions having different phase difference characteristics is referred to as a patterned phase difference material.

패턴화 위상차재는, 예를 들어, 특허문헌 1에 개시되는 바와 같이, 중합성 액정으로 이루어지는 위상차재료를 광학패터닝함으로써 제작할 수 있다. 중합성 액정으로 이루어지는 위상차재료의 광학패터닝은, 액정패널의 배향재 형성에서 알려진 광배향기술을 이용한다. 즉, 기판 상에 광배향성의 재료로 이루어지는 도막을 마련하고, 이것에 편광방향이 상이한 2종류의 편광을 조사한다. 그리고, 액정의 배향제어방향이 상이한 2종류의 액정배향영역이 형성된 배향재로서 광배향막을 얻는다. 이 광배향막의 위에 중합성 액정을 포함하는 용액상의 위상차재료를 도포하고, 중합성 액정의 배향을 실현한다. 그 후, 배향된 중합성 액정을 경화하여 패턴화 위상차재를 형성한다.A patterned retardation material can be produced by optically patterning the retardation material which consists of a polymeric liquid crystal, as disclosed by patent document 1, for example. The optical patterning of the retardation material made of a polymerizable liquid crystal uses a photo-alignment technique known in the formation of an alignment material of a liquid crystal panel. That is, a coating film made of a material of optical orientation is provided on a substrate, and two types of polarized light having different polarization directions are irradiated thereon. Then, a photo-alignment film is obtained as an alignment material in which two types of liquid-crystal alignment regions having different orientation control directions of liquid crystal are formed. A solution phase difference material containing a polymerizable liquid crystal is applied on the photo-alignment film to achieve alignment of the polymerizable liquid crystal. Thereafter, the aligned polymerizable liquid crystal is cured to form a patterned retardation material.

유기EL디스플레이의 반사방지막은, 직선편광판, 1/4파장 위상차판에 의해 구성되며, 화상표시패널의 패널면을 향하는 외래광을 직선편광판에 의해 직선편광으로 변환하고, 계속되는 1/4파장 위상차판에 의해 원편광으로 변환한다. 여기서 이 원편광에 의한 외래광은, 화상표시패널의 표면 등에서 반사되지만, 이 반사시에 편광면의 회전방향이 역전된다. 그 결과, 이 반사광은, 도래시와는 반대로, 1/4파장 위상차판으로부터, 직선편광판에 의해 차광되는 방향의 직선편광으로 변환된 후, 계속되는 직선편광판에 의해 차광되고, 그 결과, 외부에의 출사가 현저히 억제된다.The antireflection film of the organic EL display is composed of a linear polarizing plate and a quarter-wave retardation plate, and the extraneous light directed to the panel surface of the image display panel is converted into linearly polarized light by the linear polarizing plate, followed by a quarter-wave retardation plate converted to circular polarization by Here, extraneous light due to the circularly polarized light is reflected on the surface of the image display panel or the like, but the rotational direction of the polarization plane is reversed at the time of this reflection. As a result, this reflected light is converted from the quarter-wave retardation plate to linearly polarized light in the direction blocked by the linear polarizing plate, and then blocked by the continuous linear polarizing plate. emission is significantly suppressed.

이 1/4파장 위상차판에 관하여, 특허문헌 2에는, 1/2파장판, 1/4파장판을 조합하여 1/4파장 위상차판을 구성함으로써, 이 광학필름을 역분산특성에 따라 구성하는 방법이 제안되어 있다. 이 방법의 경우, 컬러화상의 표시에 제공하는 넓은 파장대역에 있어서, 양의 분산특성에 따른 액정재료를 사용하여 역분산특성에 따라 광학필름을 구성할 수 있다.Regarding this quarter-wave retardation plate, in Patent Document 2, a quarter-wave retardation plate is constituted by combining a half-wave plate and a quarter-wave plate, whereby this optical film is constructed according to the reverse dispersion characteristics. A method is proposed. In the case of this method, in a wide wavelength band provided for display of a color image, an optical film can be constructed according to the inverse dispersion characteristic by using a liquid crystal material according to the positive dispersion characteristic.

또한 최근, 이 위상차층에 적용가능한 액정재료로서, 역분산특성을 구비하는 것이 제안되어 있다(특허문헌 3, 4). 이러한 역분산특성의 액정재료에 따르면, 1/2파장판, 1/4파장판을 조합하여 2층의 위상차층에 의해 1/4파장 위상차판을 구성하는 대신에, 위상차층을 단층에 의해 구성하여 역분산특성을 확보할 수 있고, 이에 따라 넓은 파장대역에 있어서 원하는 위상차를 확보하는 것이 가능한 광학필름을 간이한 구성에 의해 실현할 수 있다.Also, in recent years, as a liquid crystal material applicable to this retardation layer, one having an inverse dispersion characteristic has been proposed (Patent Documents 3 and 4). According to the liquid crystal material having such inverse dispersion characteristics, the retardation layer is formed by a single layer instead of forming a quarter-wave retardation plate by two retardation layers by combining a half-wave plate and a quarter-wave plate. In this way, reverse dispersion characteristics can be secured, and accordingly, an optical film capable of securing a desired retardation in a wide wavelength band can be realized with a simple configuration.

액정을 배향시키기 위해서는 배향층이 이용된다. 배향층의 형성방법으로는, 예를 들어 러빙법이나 광배향법이 알려져 있으며, 광배향법은 러빙법의 문제점인 정전기나 먼지의 발생이 없어, 정량적인 배향처리의 제어가 가능한 점에서 유용하다.An alignment layer is used to orient the liquid crystal. As a method of forming the alignment layer, for example, a rubbing method or a photo-alignment method are known, and the photo-alignment method is useful in that it does not generate static electricity or dust, which is a problem of the rubbing method, and allows quantitative control of the alignment treatment. .

광배향법을 이용한 배향재 형성에서는, 이용가능한 광배향성의 재료로서, 측쇄에 신나모일기 및 칼콘기 등의 광이량화부위를 갖는 아크릴 수지나 폴리이미드 수지 등이 알려져 있다. 이들 수지는, 편광UV조사함으로써, 액정의 배향을 제어하는 성능(이하, 액정배향성이라고도 한다.)을 나타내는 것이 보고되어 있다(특허문헌 5 내지 특허문헌 7을 참조.).In the formation of an alignment material using the photo-alignment method, an acrylic resin or polyimide resin having a photodimerization site such as a cinnamoyl group and a chalcone group in a side chain is known as a usable photo-alignment material. It has been reported that these resins exhibit the performance (hereinafter, also referred to as liquid crystal orientation) for controlling the orientation of the liquid crystal by irradiating with polarized UV light (refer to Patent Documents 5 to 7).

또한, 배향층에는, 액정배향능 외에, 내용제성이 요구된다. 예를 들어, 배향층이, 위상차재의 제조과정에서 열이나 용제에 노출되는 경우가 있다. 배향층이 용제에 도출되면, 액정배향능이 현저히 저하될 우려가 있다.Moreover, solvent resistance is calculated|required by an orientation layer other than liquid-crystal orientation ability. For example, an orientation layer may be exposed to a heat|fever or a solvent in the manufacturing process of a phase difference material. When the alignment layer is derived from a solvent, there is a fear that the liquid crystal alignment ability is remarkably lowered.

이에, 예를 들어 특허문헌 8에는, 안정된 액정배향능을 얻기 위해, 광에 의해 가교반응이 가능한 구조와 열에 의해 가교하는 구조를 갖는 중합체성분을 함유하는 액정배향제, 및, 광에 의해 가교반응이 가능한 구조를 갖는 중합체성분과 열에 의해 가교하는 구조를 갖는 화합물을 함유하는 액정배향제가 제안되어 있다.Accordingly, in Patent Document 8, for example, in order to obtain a stable liquid crystal alignment ability, a liquid crystal aligning agent containing a polymer component having a structure capable of crosslinking by light and a structure to be crosslinked by heat, and a crosslinking reaction by light A liquid crystal aligning agent containing a polymer component having this possible structure and a compound having a structure crosslinked by heat has been proposed.

일본특허공개 2005-49865호 공보Japanese Patent Laid-Open No. 2005-49865 일본특허공개 H10-68816호 공보Japanese Patent Laid-Open No. H10-68816 미국특허 제8119026호 명세서US Patent No. 8119026 Specification 일본특허공개 2009-179563호 공보Japanese Patent Laid-Open No. 2009-179563 일본특허 제3611342호 공보Japanese Patent No. 3611342 publication 일본특허공개 2009-058584호 공보Japanese Patent Laid-Open No. 2009-058584 일본특허공표 2001-517719호 공보Japanese Patent Publication No. 2001-517719 일본특허 제4207430호 공보Japanese Patent No. 4207430

이상과 같이, 위상차재는, 배향재인 광배향막의 위에, 경화된 중합성 액정의 층을 적층하여 구성된다. 이에 따라, 우수한 액정배향성과 내용제성을 양립할 수 있는 배향재의 개발이 필요시되고 있다.As mentioned above, the retardation material laminates|stacks the layer of the hardened|cured polymeric liquid crystal on the photo-alignment film which is an orientation material, and is comprised. Accordingly, there is a need for development of an alignment material that is compatible with excellent liquid crystal alignment and solvent resistance.

그러나, 본 발명자의 검토에 따르면, 측쇄에 신나모일기나 칼콘기 등의 광이량화부위를 갖는 아크릴 수지는, 위상차재의 형성에 적용한 경우에 충분한 특성이 얻어지지 않는 것을 알고 있다. 특히, 이들 수지에 편광UV를 조사하여 배향재를 형성하고, 그 배향재를 이용하여 중합성 액정으로 이루어지는 위상차재를 제작하기 위해서는, 큰 편광UV노광량이 필요해진다. 그 편광UV노광량은, 통상의 액정패널용의 액정을 배향시키기에 충분한 편광UV노광량(예를 들어, 30mJ/cm2 정도.)보다 현격히 많아진다.However, according to the examination of the present inventors, it is known that sufficient characteristics are not obtained when the acrylic resin which has photodimerization sites, such as a cinnamoyl group and a chalcone group, in a side chain is applied to formation of retardation material. In particular, in order to form an orientation material by irradiating these resin with polarized light UV, and to produce the retardation material which consists of a polymerizable liquid crystal using the orientation material, a large polarization|polarized-light UV exposure amount is required. The polarized UV exposure amount is significantly higher than the polarized UV exposure dose sufficient to orient the liquid crystal for a normal liquid crystal panel (for example, about 30 mJ/cm 2 .).

편광UV노광량이 많아지는 이유로는, 위상차재 형성의 경우, 액정패널용의 액정과 달리, 중합성 액정이 용액의 상태로 이용되고, 배향재의 위에 도포되는 것을 들 수 있다.The reason that the amount of polarized UV exposure increases, in the case of retardation material formation, unlike the liquid crystal for liquid crystal panels, a polymerizable liquid crystal is used in the state of a solution, and it is mentioned that it is apply|coated on the alignment material.

측쇄에 신나모일기 등의 광이량화부위를 갖는 아크릴 수지 등을 이용하여 배향재를 형성하고, 중합성 액정을 배향시키고자 하는 경우, 그 아크릴 수지 등에 있어서는, 광이량화반응에 의한 광가교를 행한다. 그리고, 중합성 액정용액에 대한 내성이 발현될 때까지, 큰 노광량의 편광조사를 행할 필요가 있다. 액정패널의 액정을 배향시키기 위해서는, 통상, 광배향성의 배향재의 표면만을 이량화반응하면 된다. 그러나, 상기 서술한 아크릴 수지 등의 종래재료를 이용하여 배향재에 용제내성을 발현시키고자 하면, 배향재의 내부까지 반응을 시킬 필요가 있어, 보다 많은 노광량이 필요해진다. 그 결과, 종래재료의 배향감도는 매우 작아진다는 문제가 있었다.When an alignment material is formed using an acrylic resin having a photodimerization site such as a cinnamoyl group in the side chain, and the polymerizable liquid crystal is to be oriented, in the acrylic resin, photocrosslinking by photodimerization reaction is performed. do And it is necessary to perform polarized light irradiation with a large exposure amount until resistance with respect to a polymeric liquid crystal solution is expressed. In order to orientate the liquid crystal of a liquid crystal panel, it is good to dimerize only the surface of the orientation material of a photo-alignment property normally. However, when it is intended to express solvent resistance in an orientation material using conventional materials, such as an acrylic resin mentioned above, it is necessary to make it react to the inside of an orientation material, and more exposure amount is required. As a result, there existed a problem that the orientation sensitivity of the conventional material became very small.

또한, 상기 서술한 종래재료인 수지에 이러한 용제내성을 발현시키기 위해, 가교제를 첨가하는 기술이 알려져 있다. 그러나, 가교제에 의한 열경화반응을 행한 후, 형성되는 도막의 내부에는 3차원구조가 형성되며, 광반응성은 저하되는 것을 알고 있다. 즉, 배향감도가 크게 저하되어, 종래재료에 가교제를 첨가하여 사용해도, 원하는 효과는 얻지 못한다.In addition, in order to express such solvent resistance to the resin which is the above-mentioned conventional material, the technique of adding a crosslinking agent is known. However, it is known that after thermosetting reaction with a crosslinking agent, a three-dimensional structure is formed inside the formed coating film, and the photoreactivity is lowered. That is, the orientation sensitivity is greatly reduced, and even if a crosslinking agent is added to the conventional material and used, the desired effect cannot be obtained.

나아가, 액정잉크에는 여러가지 유기용매가 사용되는데, 기판으로서, 유기용매에 대해 내성이 낮은 필름이 사용되는 경우가 있어, 필름의 보호라는 이유로, 용제내성이 높은 배향막이 요구되고 있다.Furthermore, although various organic solvents are used for liquid crystal ink, as a substrate, a film with low resistance to organic solvents is sometimes used, and for the reason of film protection, an alignment film with high solvent resistance is required.

이상으로부터, 배향재의 배향감도를 향상시키고, 편광UV노광량을 저감할 수 있는 광배향기술과, 그 배향재의 형성에 이용되는 광배향용 액정배향제로서 이용할 수 있는 경화막 형성 조성물이 요구되고 있다. 그리고, 고효율로 위상차재를 제공할 수 있는 기술이 요구되고 있다.From the above, a cured film forming composition that can be used as a liquid crystal aligning agent for photo-alignment used in the formation of a photo-alignment technique that can improve the orientation sensitivity of the orientation material and reduce the amount of polarized UV exposure and the orientation material is required. In addition, there is a demand for a technique capable of providing a phase difference material with high efficiency.

본 발명의 목적은, 이상의 지견이나 검토결과에 기초하여 이루어진 것이다. 즉, 본 발명의 목적은, 우수한 배향감도를 가지며, 배향균일성도 우수함과 함께, 박막이어도 액정용액 중의 용제에 대한 내성을 가지고, 필름기판을 보호하는 보호층으로서도 기능할 수 있는 배향재를 제공하기 위한 광배향용 액정배향제로서 이용할 수 있는 경화막 형성 조성물을 제공하는 것이다.The objective of this invention was achieved based on the above knowledge and examination result. That is, an object of the present invention is to provide an alignment material that has excellent alignment sensitivity, excellent alignment uniformity, and has resistance to solvents in liquid crystal solutions even if it is a thin film, and can function as a protective layer to protect the film substrate It is to provide a cured film forming composition that can be used as a liquid crystal aligning agent for optical alignment.

본 발명의 다른 목적 및 이점은, 이하의 기재로부터 명백해질 것이다.Other objects and advantages of the present invention will become apparent from the following description.

본 발명의 제1의 태양은,A first aspect of the present invention is

(A)광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는 화합물,(A) a compound having a photo-alignment group and one substituent selected from the group consisting of a hydroxyl group, a carboxyl group and an amino group;

(B)적어도 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머, 그리고(B) a polymer formed by polymerizing a monomer containing at least an N-alkoxymethyl (meth)acrylamide compound, and

(C)적어도 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머를 함유하는 것을 특징으로 하는 경화막 형성 조성물에 관한 것이다.(C) It contains the polymer formed by polymerizing the monomer containing at least N-hydroxyalkyl (meth)acrylamide compound, It relates to the cured film formation composition characterized by the above-mentioned.

본 발명의 제1의 태양에 있어서, (A)성분의 광배향성기가 광이량화 또는 광이성화하는 구조의 관능기인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the photo-alignment group of (A) component is a functional group of the structure into which photodimerization or photoisomerization is carried out.

본 발명의 제1의 태양에 있어서, (A)성분의 광배향성기가 신나모일기인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the photo-alignment group of (A) component is a cinnamoyl group.

본 발명의 제1의 태양에 있어서, (A)성분의 광배향성기가 아조벤젠구조의 기인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the photo-alignment group of (A) component is group of an azobenzene structure.

본 발명의 제1의 태양에 있어서, (D)성분으로서, 가교촉매를 추가로 함유하는 것이 바람직하다.1st aspect of this invention WHEREIN: As (D)component, it is preferable to contain a crosslinking catalyst further.

본 발명의 제1의 태양에 있어서, (E)성분으로서, 밀착향상성분을 추가로 함유하는 것이 바람직하다.1st aspect of this invention WHEREIN: As (E) component, it is preferable to contain an adhesion|adherence improving component further.

본 발명의 제1의 태양에 있어서, (A)성분의 100질량부에 기초하여, (B)성분과 (C)성분의 합계량이 100 내지 3000질량부인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that the total amount of (B) component and (C)component is 100-3000 mass parts based on 100 mass parts of (A) component.

본 발명의 제1의 태양에 있어서, (B)성분과 (C)성분의 질량비가 1:99 내지 99:1인 것이 바람직하다.1st aspect of this invention WHEREIN: It is preferable that mass ratio of (B)component and (C)component is 1:99-99:1.

본 발명의 제1의 태양에 있어서, (B)성분과 (C)성분의 합계량 100질량부에 기초하여, 0.01질량부 내지 10질량부의 (D)성분을 함유하는 것이 바람직하다.1st aspect of this invention WHEREIN: Based on 100 mass parts of total amounts of (B) component and (C)component, it is preferable to contain 0.01 mass part - 10 mass parts (D)component.

본 발명의 제2의 태양은, 본 발명의 제1의 태양의 경화막 형성 조성물을 이용하여 얻어지는 것을 특징으로 하는 배향재에 관한 것이다.A 2nd aspect of this invention is obtained using the cured film formation composition of a 1st aspect of this invention, It relates to the orientation material characterized by the above-mentioned.

본 발명의 제3의 태양은, 본 발명의 제1의 태양의 경화막 형성 조성물로부터 얻어지는 경화막을 사용하여 형성되는 것을 특징으로 하는 위상차재에 관한 것이다.A 3rd aspect of this invention is formed using the cured film obtained from the cured film formation composition of the 1st aspect of this invention, It relates to the retardation material characterized by the above-mentioned.

본 발명의 제1의 태양에 따르면, 우수한 배향감도를 가지며, 배향균일성도 우수함과 함께, 박막이어도 액정용액 중의 용제에 대한 내성을 가지고, 필름기판을 보호하는 보호층으로서도 기능할 수 있는 배향재를 제공하기 위한 경화막 형성 조성물을 제공할 수 있다.According to the first aspect of the present invention, an alignment material that has excellent alignment sensitivity and excellent alignment uniformity, has resistance to solvents in liquid crystal solutions even in thin films, and can function as a protective layer to protect the film substrate The cured film formation composition for providing can be provided.

본 발명의 제2의 태양에 따르면, 우수한 배향감도를 가지며, 배향균일성도 우수함과 함께, 박막이어도 액정용액중의 용제에 대한 내성을 가지고, 필름기판을 보호하는 보호층으로서도 기능할 수 있는 배향재를 제공할 수 있다.According to the second aspect of the present invention, an alignment material that has excellent alignment sensitivity and excellent alignment uniformity, has resistance to solvents in liquid crystal solutions even in thin films, and can function as a protective layer to protect the film substrate can provide

본 발명의 제3의 태양에 따르면, 필름기판 상에서도 높은 효율로 형성할 수 있어, 광학패터닝이 가능한 위상차재를 제공할 수 있다.According to the third aspect of the present invention, it is possible to provide a retardation material that can be formed with high efficiency even on a film substrate and can be optically patterned.

<경화막 형성 조성물><Cured film forming composition>

본 발명의 경화막 형성 조성물은, (A)성분인 광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는 화합물(이하 「저분자의 광배향성분」이라고도 기재한다.)과, (B)성분인 적어도 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머와, (C)성분인 적어도 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머를 함유한다. 본 발명의 경화막 형성 조성물은, (A)성분, (B)성분, (C)성분에 더하여, 추가로, (D)성분으로서 가교촉매, (E)성분으로서 경화막의 밀착성을 향상시키는 성분도 함유할 수 있다. 그리고, 본 발명의 효과를 손상시키지 않는 한, 기타 첨가제를 함유할 수 있다.The cured film forming composition of the present invention is a compound having one substituent selected from the group consisting of a photo-alignment group as the component (A), a hydroxyl group, a carboxyl group, and an amino group (hereinafter, also referred to as a “low-molecular photo-alignment component”. ) and a polymer formed by polymerizing a monomer containing at least N-alkoxymethyl (meth)acrylamide compound as component (B), and at least N-hydroxyalkyl (meth)acrylamide compound as component (C) A polymer formed by polymerizing a monomer is contained. In addition to (A) component, (B) component, and (C)component, the cured film formation composition of this invention also contains the component which improves the adhesiveness of a cured film as a crosslinking catalyst and (E) component as (D)component further can do. In addition, other additives may be contained as long as the effects of the present invention are not impaired.

이하, 각 성분의 상세를 설명한다.Hereinafter, the detail of each component is demonstrated.

<(A)성분><(A) component>

본 발명의 경화막 형성 조성물에 함유되는 (A)성분은, 상기 서술한, 저분자의 광배향성분이다.(A) component contained in the cured film formation composition of this invention is the above-mentioned low molecular photo-alignment component.

그리고, (A)성분인 저분자의 광배향성분은, 광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는 화합물이다. 광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는 화합물에 있어서는, 상기 서술한 바와 같이, 광배향성기가 광에 반응하여 소수성의 광배향부를 구성하고, 하이드록시기 등이 친수성의 열반응부를 구성한다.And the low-molecular photo-alignment component which is (A) component is a compound which has a photo-alignment group and one substituent selected from the group which consists of a hydroxyl group, a carboxyl group, and an amino group. In the compound having one substituent selected from the group consisting of a photo-alignment group, a hydroxyl group, a carboxyl group, and an amino group, the photo-alignment group reacts to light to form a hydrophobic photo-alignment part, as described above, and a hydroxyl group and the like constitute a hydrophilic thermal reaction zone.

한편, 본 발명에 있어서, 광배향성기란 광이량화 또는 광이성화하는 구조부위의 관능기를 말한다.On the other hand, in the present invention, the photo-alignment group refers to a functional group of a structural site to be photodimerized or photoisomerized.

광이량화하는 구조부위란, 광조사에 의해 이량체를 형성하는 부위이며, 그 구체예로는 신나모일기, 칼콘기, 쿠마린기, 안트라센기 등을 들 수 있다. 이들 중 가시광영역에서의 높은 투명성 및 광이량화반응성을 갖는 신나모일기가 바람직하다. 또한, 광이성화하는 구조부위란, 광조사에 의해 시스체와 트랜스체로 변하는 구조부위를 가리키며, 그 구체예로는 아조벤젠구조, 스틸벤구조 등으로 이루어지는 부위를 들 수 있다. 이들 중 반응성의 높이로부터 아조벤젠구조가 바람직하다. 광배향성기와 하이드록시기를 갖는 화합물은, 예를 들어, 하기 식으로 표시된다.The structural site for photodimerization is a site for forming a dimer by irradiation with light, and specific examples thereof include a cinnamoyl group, a chalcone group, a coumarin group, an anthracene group, and the like. Among them, a cinnamoyl group having high transparency and photodimerization reactivity in the visible region is preferable. In addition, the structural moiety to be photoisomerized refers to a structural moiety that changes into a cis-form and a trans-form upon irradiation with light, and specific examples thereof include a moiety composed of an azobenzene structure, a stilbene structure, and the like. Among these, the azobenzene structure is preferable from the height of reactivity. The compound which has a photo-alignment group and a hydroxyl group is represented by a following formula, for example.

[화학식 1][Formula 1]

Figure pct00001
Figure pct00001

상기 식[A1] 내지 식[A5] 중, A1과 A2는 각각 독립적으로, 수소원자 또는 메틸기를 나타내고, X1은 단결합, 에테르결합, 에스테르결합, 아미드결합, 우레탄결합, 아미노결합 또는 그들의 조합으로부터 선택되는 1종 또는 2종 이상의 결합을 개재하여, 탄소원자수 1 내지 18의 알킬렌기, 페닐렌기, 비페닐렌기 또는 그들의 조합으로부터 선택되는 1 내지 3의 기가 결합하여 이루어지는 2가의 기를 나타낸다. X2는 수소원자, 할로겐원자, 시아노기, 탄소원자수 1 내지 18의 알킬기, 페닐기, 비페닐기 또는 시클로헥실기를 나타낸다. 그 때, 탄소원자수 1 내지 18의 알킬기, 페닐기, 비페닐기 및 시클로헥실기는, 공유결합, 에테르결합, 에스테르결합, 아미드결합 또는 요소결합을 개재하여 벤젠환과 결합할 수도 있다. X5는 하이드록시기, 카르복실기, 아미노기 또는 알콕시실릴기를 나타낸다. X는 단결합, 산소원자 또는 황원자를 나타낸다. X6은 하이드록시기, 메르캅토기, 탄소원자수 1 내지 10의 알콕시기, 탄소원자수 1 내지 10의 알킬티오기, 페닐기, 페녹시기 또는 비페녹시기를 나타낸다. X7은 단결합, 탄소원자수 1 내지 20의 알킬렌기, 방향족환으로부터 수소원자를 2개 제거한 2가의 기, 또는, 지방족환으로부터 수소원자를 2개 제거한 2가의 기를 나타낸다. 여기서 탄소원자수 1 내지 20의 알킬렌기는 분지상이어도 직쇄상일 수도 있다.In the formulas [A1] to [A5], A 1 and A 2 each independently represent a hydrogen atom or a methyl group, and X 1 is a single bond, an ether bond, an ester bond, an amide bond, a urethane bond, an amino bond, or A divalent group formed by bonding 1 to 3 groups selected from an alkylene group having 1 to 18 carbon atoms, a phenylene group, a biphenylene group, or a combination thereof through one or more bonds selected from combinations thereof. X 2 represents a hydrogen atom, a halogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group or a cyclohexyl group. In that case, the alkyl group, phenyl group, biphenyl group and cyclohexyl group having 1 to 18 carbon atoms may be bonded to the benzene ring via a covalent bond, an ether bond, an ester bond, an amide bond or a urea bond. X 5 represents a hydroxyl group, a carboxyl group, an amino group, or an alkoxysilyl group. X represents a single bond, an oxygen atom or a sulfur atom. X 6 represents a hydroxy group, a mercapto group, an alkoxy group having 1 to 10 carbon atoms, an alkylthio group having 1 to 10 carbon atoms, a phenyl group, a phenoxy group or a biphenoxy group. X 7 represents a single bond, an alkylene group having 1 to 20 carbon atoms, a divalent group obtained by removing two hydrogen atoms from an aromatic ring, or a divalent group obtained by removing two hydrogen atoms from an aliphatic ring. Here, the alkylene group having 1 to 20 carbon atoms may be branched or linear.

한편, 이들 치환기에 있어서, 페닐렌기, 페닐기, 비페닐렌기, 비페닐기, 페녹시기 및 비페녹시기는, 탄소원자수 1 내지 4의 알킬기, 탄소원자수 1 내지 4의 알콕시기, 할로겐원자, 트리플루오로메틸기 및 시아노기로부터 선택되는 동일 또는 상이한 1 또는 복수의 치환기에 의해 치환되어 있을 수도 있다.On the other hand, in these substituents, a phenylene group, a phenyl group, a biphenylene group, a biphenyl group, a phenoxy group and a biphenoxy group are an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, trifluoro It may be substituted by the same or different 1 or several substituents selected from a methyl group and a cyano group.

상기 식 중, R1, R2, R3, R4, R5, R6, R7 및 R8은, 각각 독립적으로 수소원자, 탄소원자수 1 내지 4의 알킬기, 탄소원자수 1 내지 4의 알콕시기, 할로겐원자, 트리플루오로메틸기 또는 시아노기를 나타낸다.In the above formula, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or alkoxy having 1 to 4 carbon atoms. group, a halogen atom, a trifluoromethyl group or a cyano group.

상기 탄소원자수 1 내지 18의 알킬기로는, 예를 들어, 메틸기, 에틸기, n-프로필기, 이소프로필기, n-부틸기, 이소부틸기, sec-부틸기, tert-부틸기, n-펜틸기, 1-메틸-n-부틸기, 2-메틸-n-부틸기, 3-메틸-n-부틸기, 1,1-디메틸-n-프로필기, 1,2-디메틸-n-프로필기, 2,2-디메틸-n-프로필기, 1-에틸-n-프로필기, n-헥실기, 1-메틸-n-펜틸기, 2-메틸-n-펜틸기, 3-메틸-n-펜틸기, 4-메틸-n-펜틸기, 1,1-디메틸-n-부틸기, 1,2-디메틸-n-부틸기, 1,3-디메틸-n-부틸기, 2,2-디메틸-n-부틸기, 2,3-디메틸-n-부틸기, 3,3-디메틸-n-부틸기, 1-에틸-n-부틸기, 2-에틸-n-부틸기, 1,1,2-트리메틸-n-프로필기, 1,2,2-트리메틸-n-프로필기, 1-에틸-1-메틸-n-프로필기, 1-에틸-2-메틸-n-프로필기, n-헵틸기, 1-메틸-n-헥실기, 2-메틸-n-헥실기, 3-메틸-n-헥실기, 1,1-디메틸-n-펜틸기, 1,2-디메틸-n-펜틸기, 1,3-디메틸-n-펜틸기, 2,2-디메틸-n-펜틸기, 2,3-디메틸-n-펜틸기, 3,3-디메틸-n-펜틸기, 1-에틸-n-펜틸기, 2-에틸-n-펜틸기, 3-에틸-n-펜틸기, 1-메틸-1-에틸-n-부틸기, 1-메틸-2-에틸-n-부틸기, 1-에틸-2-메틸-n-부틸기, 2-메틸-2-에틸-n-부틸기, 2-에틸-3-메틸-n-부틸기, n-옥틸기, 1-메틸-n-헵틸기, 2-메틸-n-헵틸기, 3-메틸-n-헵틸기, 1,1-디메틸-n-헥실기, 1,2-디메틸-n-헥실기, 1,3-디메틸-n-헥실기, 2,2-디메틸-n-헥실기, 2,3-디메틸-n-헥실기, 3,3-디메틸-n-헥실기, 1-에틸-n-헥실기, 2-에틸-n-헥실기, 3-에틸-n-헥실기, 1-메틸-1-에틸-n-펜틸기, 1-메틸-2-에틸-n-펜틸기, 1-메틸-3-에틸-n-펜틸기, 2-메틸-2-에틸-n-펜틸기, 2-메틸-3-에틸-n-펜틸기, 3-메틸-3-에틸-n-펜틸기, n-노닐기, n-데실기, n-운데실기, n-도데실기, n-트리데실기, n-테트라데실기, n-펜타데실기, n-헥사데실기, n-헵타데실기 및 n-옥타데실기 등을 들 수 있다.Examples of the alkyl group having 1 to 18 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-pene Tyl group, 1-methyl-n-butyl group, 2-methyl-n-butyl group, 3-methyl-n-butyl group, 1,1-dimethyl-n-propyl group, 1,2-dimethyl-n-propyl group , 2,2-dimethyl-n-propyl group, 1-ethyl-n-propyl group, n-hexyl group, 1-methyl-n-pentyl group, 2-methyl-n-pentyl group, 3-methyl-n- Pentyl group, 4-methyl-n-pentyl group, 1,1-dimethyl-n-butyl group, 1,2-dimethyl-n-butyl group, 1,3-dimethyl-n-butyl group, 2,2-dimethyl -n-butyl group, 2,3-dimethyl-n-butyl group, 3,3-dimethyl-n-butyl group, 1-ethyl-n-butyl group, 2-ethyl-n-butyl group, 1,1, 2-trimethyl-n-propyl group, 1,2,2-trimethyl-n-propyl group, 1-ethyl-1-methyl-n-propyl group, 1-ethyl-2-methyl-n-propyl group, n- Heptyl group, 1-methyl-n-hexyl group, 2-methyl-n-hexyl group, 3-methyl-n-hexyl group, 1,1-dimethyl-n-pentyl group, 1,2-dimethyl-n-pene Tyl group, 1,3-dimethyl-n-pentyl group, 2,2-dimethyl-n-pentyl group, 2,3-dimethyl-n-pentyl group, 3,3-dimethyl-n-pentyl group, 1-ethyl- n-pentyl group, 2-ethyl-n-pentyl group, 3-ethyl-n-pentyl group, 1-methyl-1-ethyl-n-butyl group, 1-methyl-2-ethyl-n-butyl group, 1 -Ethyl-2-methyl-n-butyl group, 2-methyl-2-ethyl-n-butyl group, 2-ethyl-3-methyl-n-butyl group, n-octyl group, 1-methyl-n-hep group Tyl group, 2-methyl-n-heptyl group, 3-methyl-n-heptyl group, 1,1-dimethyl-n-hexyl group, 1,2-dimethyl-n-hexyl group, 1,3-dimethyl-n- Hexyl group, 2,2-dimethyl-n-hexyl group, 2,3-dimethyl-n-hexyl group, 3,3-dimethyl-n-hexyl group, 1-ethyl-n-hexyl group, 2-ethyl-n -Hexyl group, 3-ethyl-n-hexyl group, 1-methyl-1-ethyl-n-pentyl group, 1-methyl-2-ethyl-n-pentyl group, 1-methyl-3-ethyl-n-pene Tyl group, 2-methyl-2-ethyl-n-pentyl group, 2-methyl-3-ethyl-n-pentyl group, 3-methyl-3-ethyl-n-pentyl group, n-nonyl group, n-decyl group , n-undecyl group, n-dodecyl group, n-tridecyl group , n-tetradecyl group, n-pentadecyl group, n-hexadecyl group, n-heptadecyl group and n-octadecyl group etc. are mentioned.

상기 탄소원자수 1 내지 18의 알킬렌기로는, 상기에 언급한 알킬기로부터 수소원자를 1개 제거한 2가의 기를 들 수 있다.Examples of the alkylene group having 1 to 18 carbon atoms include a divalent group obtained by removing one hydrogen atom from the above-mentioned alkyl group.

상기 탄소원자수 1 내지 4의 알킬기로는, 상기에 언급한 기 중 해당하는 탄소원자수의 기를 들 수 있다.Examples of the alkyl group having 1 to 4 carbon atoms include a group having the corresponding number of carbon atoms among the groups mentioned above.

상기 탄소원자수 1 내지 10의 알콕시기, 탄소원자수 1 내지 4의 알콕시기, 탄소원자수 1 내지 10의 알킬티오기로는, 상기에 언급한 알킬기를 옥시화 또는 티오화한 기 중 해당하는 탄소원자수의 기를 들 수 있다.As the alkoxy group having 1 to 10 carbon atoms, the alkoxy group having 1 to 4 carbon atoms, and the alkylthio group having 1 to 10 carbon atoms, a group having the corresponding number of carbon atoms among the above-mentioned alkyl groups oxidized or thiolated can be heard

상기 탄소원자수 1 내지 20의 알킬렌기로는, 상기 알킬기 그리고 n-노나데실기, n-에이코실기 등의 탄소원자수 1 내지 20의 알킬기로부터 수소원자를 1개 제거한 2가의 기를 들 수 있다.Examples of the alkylene group having 1 to 20 carbon atoms include a divalent group obtained by removing one hydrogen atom from the alkyl group and an alkyl group having 1 to 20 carbon atoms, such as the n-nonadecyl group and n-eicosyl group.

(A)성분인 광배향성기와 하이드록시기를 갖는 화합물의 구체예로는, 예를 들어, 4-(8-하이드록시옥틸옥시)계피산메틸에스테르, 4-(6-하이드록시헥실옥시)계피산메틸에스테르, 4-(4-하이드록시부틸옥시)계피산메틸에스테르, 4-(3-하이드록시프로필옥시)계피산메틸에스테르, 4-(2-하이드록시에틸옥시)계피산메틸에스테르, 4-하이드록시메틸옥시계피산메틸에스테르, 4-하이드록시계피산메틸에스테르, 4-(8-하이드록시옥틸옥시)계피산에틸에스테르, 4-(6-하이드록시헥실옥시)계피산에틸에스테르, 4-(4-하이드록시부틸옥시)계피산에틸에스테르, 4-(3-하이드록시프로필옥시)계피산에틸에스테르, 4-(2-하이드록시에틸옥시)계피산에틸에스테르, 4-하이드록시메틸옥시계피산에틸에스테르, 4-하이드록시계피산에틸에스테르, 4-(8-하이드록시옥틸옥시)계피산페닐에스테르, 4-(6-하이드록시헥실옥시)계피산페닐에스테르, 4-(4-하이드록시부틸옥시)계피산페닐에스테르, 4-(3-하이드록시프로필옥시)계피산페닐에스테르, 4-(2-하이드록시에틸옥시)계피산페닐에스테르, 4-하이드록시메틸옥시계피산페닐에스테르, 4-하이드록시계피산페닐에스테르, 4-(8-하이드록시옥틸옥시)계피산비페닐에스테르, 4-(6-하이드록시헥실옥시)계피산비페닐에스테르, 4-(4-하이드록시부틸옥시)계피산비페닐에스테르, 4-(3-하이드록시프로필옥시)계피산비페닐에스테르, 4-(2-하이드록시에틸옥시)계피산비페닐에스테르, 4-하이드록시메틸옥시계피산비페닐에스테르, 4-하이드록시계피산비페닐에스테르, 계피산8-하이드록시옥틸에스테르, 계피산6-하이드록시헥실에스테르, 계피산4-하이드록시부틸에스테르, 계피산3-하이드록시프로필에스테르, 계피산2-하이드록시에틸에스테르, 계피산하이드록시메틸에스테르, 4-(8-하이드록시옥틸옥시)아조벤젠, 4-(6-하이드록시헥실옥시)아조벤젠, 4-(4-하이드록시부틸옥시)아조벤젠, 4-(3-하이드록시프로필옥시)아조벤젠, 4-(2-하이드록시에틸옥시)아조벤젠, 4-하이드록시메틸옥시아조벤젠, 4-하이드록시아조벤젠, 4-(8-하이드록시옥틸옥시)칼콘, 4-(6-하이드록시헥실옥시)칼콘, 4-(4-하이드록시부틸옥시)칼콘, 4-(3-하이드록시프로필옥시)칼콘, 4-(2-하이드록시에틸옥시)칼콘, 4-하이드록시메틸옥시칼콘, 4-하이드록시칼콘, 4’-(8-하이드록시옥틸옥시)칼콘, 4’-(6-하이드록시헥실옥시)칼콘, 4’-(4-하이드록시부틸옥시)칼콘, 4’-(3-하이드록시프로필옥시)칼콘, 4’-(2-하이드록시에틸옥시)칼콘, 4’-하이드록시메틸옥시칼콘, 4’-하이드록시칼콘, 7-(8-하이드록시옥틸옥시)쿠마린, 7-(6-하이드록시헥실옥시)쿠마린, 7-(4-하이드록시부틸옥시)쿠마린, 7-(3-하이드록시프로필옥시)쿠마린, 7-(2-하이드록시에틸옥시)쿠마린, 7-하이드록시메틸옥시쿠마린, 7-하이드록시쿠마린, 6-하이드록시옥틸옥시쿠마린, 6-하이드록시헥실옥시쿠마린, 6-(4-하이드록시부틸옥시)쿠마린, 6-(3-하이드록시프로필옥시)쿠마린, 6-(2-하이드록시에틸옥시)쿠마린, 6-하이드록시메틸옥시쿠마린, 6-하이드록시쿠마린을 들 수 있다.(A) As a specific example of the compound which has the photo-alignment group which is a component and a hydroxyl group, 4-(8-hydroxyoctyloxy) methyl cinnamic acid, 4-(6-hydroxyhexyloxy) methyl cinnamate, for example Ester, 4-(4-hydroxybutyloxy) cinnamic acid methyl ester, 4-(3-hydroxypropyloxy) cinnamic acid methyl ester, 4-(2-hydroxyethyloxy) cinnamic acid methyl ester, 4-hydroxymethyloxy Cinnamon methyl ester, 4-hydroxycinnamic acid methyl ester, 4-(8-hydroxyoctyloxy) cinnamic acid ethyl ester, 4-(6-hydroxyhexyloxy) cinnamic acid ethyl ester, 4-(4-hydroxybutyloxy) ) Cinnamon ethyl ester, 4-(3-hydroxypropyloxy) cinnamic acid ethyl ester, 4-(2-hydroxyethyloxy) cinnamic acid ethyl ester, 4-hydroxymethyloxy cinnamic acid ethyl ester, 4-hydroxycinnamic acid ethyl ester , 4- (8-hydroxyoctyloxy) cinnamic acid phenyl ester, 4- (6-hydroxyhexyloxy) cinnamic acid phenyl ester, 4- (4-hydroxybutyloxy) cinnamic acid phenyl ester, 4- (3-hydroxy) hydroxypropyloxy) cinnamic acid phenyl ester, 4-(2-hydroxyethyloxy) cinnamic acid phenyl ester, 4-hydroxymethyloxy cinnamic acid phenyl ester, 4-hydroxycinnamic acid phenyl ester, 4-(8-hydroxyoctyloxy) Cinnamon acid biphenyl ester, 4-(6-hydroxyhexyloxy) cinnamic acid biphenyl ester, 4-(4-hydroxybutyloxy) cinnamic acid biphenyl ester, 4-(3-hydroxypropyloxy) cinnamic acid biphenyl ester , 4-(2-hydroxyethyloxy)cinnamic acid biphenyl ester, 4-hydroxymethyloxycinnamic acid biphenyl ester, 4-hydroxycinnamic acid biphenyl ester, cinnamic acid 8-hydroxyoctyl ester, cinnamic acid 6-hydroxyhexyl Ester, cinnamic acid 4-hydroxybutyl ester, cinnamic acid 3-hydroxypropyl ester, cinnamic acid 2-hydroxyethyl ester, cinnamic acid hydroxymethyl ester, 4-(8-hydroxyoctyloxy) azobenzene, 4-(6-hydro hydroxyhexyloxy) azobenzene, 4-(4-hydroxybutyloxy) azobenzene, 4-(3-hydroxypropyloxy) azobenzene, 4-(2-hydroxyethyloxy) azobenzene, 4-hydroxymethyloxyazobenzene , 4-hydroxyazobenzene, 4- (8-hydroxyoctyloxy) chalcone, 4- ( 6-hydroxyhexyloxy) chalcone, 4- (4-hydroxybutyloxy) chalcone, 4- (3-hydroxypropyloxy) chalcone, 4- (2-hydroxyethyloxy) chalcone, 4-hydroxy Methyloxychalcone, 4-hydroxychalcone, 4'-(8-hydroxyoctyloxy)chalcone, 4'-(6-hydroxyhexyloxy)chalcone, 4'-(4-hydroxybutyloxy)chalcone, 4'-(3-hydroxypropyloxy)chalcone, 4'-(2-hydroxyethyloxy)chalcone, 4'-hydroxymethyloxychalcone, 4'-hydroxychalcone, 7-(8-hydroxyoctyl) Oxy)coumarin, 7-(6-hydroxyhexyloxy)coumarin, 7-(4-hydroxybutyloxy)coumarin, 7-(3-hydroxypropyloxy)coumarin, 7-(2-hydroxyethyloxy) ) Coumarin, 7-hydroxymethyloxycoumarin, 7-hydroxycoumarin, 6-hydroxyoctyloxycoumarin, 6-hydroxyhexyloxycoumarin, 6-(4-hydroxybutyloxy)coumarin, 6-(3- Hydroxypropyloxy) coumarin, 6-(2-hydroxyethyloxy) coumarin, 6-hydroxymethyloxy coumarin, and 6-hydroxycoumarin are mentioned.

광배향성기와 카르복실기를 갖는 화합물의 구체예로는, 계피산, 페룰산, 4-니트로계피산, 4-메톡시계피산, 3,4-디메톡시계피산, 쿠마린-3-카르본산, 4-(디메틸아미노)계피산 등을 들 수 있다.Specific examples of the compound having a photo-alignment group and a carboxyl group include cinnamic acid, ferulic acid, 4-nitrocinnamic acid, 4-methoxycinnamic acid, 3,4-dimethoxycinnamic acid, coumarin-3-carboxylic acid, 4-(dimethylamino) cinnamic acid and the like.

광배향성기와 아미노기를 갖는 화합물의 구체예로는, 4-아미노계피산메틸, 4-아미노계피산에틸, 3-아미노계피산메틸, 3-아미노계피산에틸 등을 들 수 있다.Specific examples of the compound having a photo-alignment group and an amino group include methyl 4-aminocinnamate, ethyl 4-aminocinnamate, methyl 3-aminocinnamate, and ethyl 3-aminocinnamate.

(A)성분인 저분자의 광배향성분은, 이상의 구체예를 들 수 있는데, 이것들로 한정되는 것은 아니다.(A) Although the above specific example is given as for the low molecular photo-alignment component which is a component, it is not limited to these.

또한, (A)성분인 저분자의 광배향성분이, 광배향성기와 하이드록시기를 갖는 화합물인 경우, (A)성분으로서, 분자 내에, 광배향성기를 2개 이상 및/또는 하이드록시기를 2개 이상 갖는 화합물을 이용하는 것이 가능하다. 구체적으로는, (A)성분으로서, 분자 내에 1개의 하이드록시기와 함께 2개 이상의 광배향성기를 갖는 화합물이나, 분자 내에 1개의 광배향성기와 함께 2개 이상의 하이드록시기를 갖는 화합물이나, 분자 내에 광배향성기와 하이드록시기를 각각 2개 이상 갖는 화합물을 이용하는 것이 가능하다. 예를 들어, 분자 내에 광배향성기와 하이드록시기를 각각 2개 이상 갖는 화합물에 대해서는, 그 일례로서, 하기 식으로 표시되는 화합물을 나타낼 수 있다.In addition, when the low-molecular photo-alignment component as component (A) is a compound having a photo-alignment group and a hydroxyl group, as component (A), a compound having two or more photo-alignment groups and/or two or more hydroxyl groups in the molecule It is possible to use Specifically, as component (A), a compound having two or more photo-alignment groups together with one hydroxyl group in a molecule, a compound having two or more hydroxyl groups together with one photo-alignment group in a molecule, and photo-alignment property in a molecule It is possible to use compounds each having two or more groups and hydroxyl groups. For example, about the compound which has each two or more of photo-alignment group and a hydroxyl group in a molecule|numerator, the compound represented by the following formula can be shown as the example.

[화학식 2][Formula 2]

Figure pct00002
Figure pct00002

이러한 화합물을 적당히 선택함으로써, (A)성분인 저분자의 광배향성분의 분자량을 높이는 제어가 가능해진다. 그 결과, 후술하는 바와 같이, (A)성분인 저분자의 광배향성분 및 (B)성분인 폴리머와 (C)성분인 폴리머가 열반응할 때에, (A)성분인 저분자의 광배향성분이 승화되는 것을 억제할 수 있다. 그리고, 본 발명의 경화막 형성 조성물은, 경화막으로서, 광반응효율이 높은 배향재를 형성할 수 있다.By selecting such a compound suitably, control which raises the molecular weight of the low-molecular-weight photo-alignment component which is (A) component becomes possible. As a result, as described later, when the low-molecular photo-alignment component as component (A) and the polymer as component (B) and the polymer as component (C) thermally react, the low-molecular photo-alignment component of component (A) sublimates can be restrained And the cured film formation composition of this invention can form the orientation material with high photoreaction efficiency as a cured film.

또한, 본 발명의 경화막 형성 조성물에 있어서의 (A)성분의 화합물로는, 광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는, 복수종의 화합물의 혼합물일 수도 있다.Moreover, as a compound of (A) component in the cured film formation composition of this invention, it has a photo-alignment group, and one substituent chosen from the group which consists of a hydroxyl group, a carboxyl group, and an amino group, The mixture of several types of compounds it may be

<(B)성분><(B) component>

본 발명의 경화막 형성 조성물에 함유되는 (B)성분은, 적어도 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머이다. 한편, N-알콕시메틸(메트)아크릴아미드란, N-알콕시메틸아크릴아미드와 N-알콕시메틸메타크릴아미드의 쌍방을 의미한다.(B) component contained in the cured film formation composition of this invention is a polymer formed by polymerizing the monomer containing at least an N-alkoxymethyl (meth)acrylamide compound. In addition, N-alkoxy methyl (meth)acrylamide means both N-alkoxy methyl acrylamide and N-alkoxy methyl methacrylamide.

그러한 폴리머로는, N-알콕시메틸(메트)아크릴아미드 화합물을 단독 또는 공중합가능한 모노머와 공중합한 폴리머를 들 수 있다. 이러한 폴리머로는, 예를 들어, 폴리(N-부톡시메틸아크릴아미드), 폴리(N-에톡시메틸아크릴아미드), 폴리(N-메톡시메틸아크릴아미드), N-부톡시메틸아크릴아미드와 스티렌의 공중합체, N-부톡시메틸아크릴아미드와 메틸메타크릴레이트의 공중합체, N-에톡시메틸메타크릴아미드와 벤질메타크릴레이트의 공중합체, 및 N-부톡시메틸아크릴아미드와 벤질메타크릴레이트와 2-하이드록시프로필메타크릴레이트의 공중합체 등을 들 수 있다.Examples of such a polymer include a polymer obtained by copolymerizing an N-alkoxymethyl (meth)acrylamide compound alone or with a copolymerizable monomer. Examples of such polymers include poly(N-butoxymethylacrylamide), poly(N-ethoxymethylacrylamide), poly(N-methoxymethylacrylamide), N-butoxymethylacrylamide and A copolymer of styrene, a copolymer of N-butoxymethyl acrylamide and methyl methacrylate, a copolymer of N-ethoxymethyl methacrylamide and benzyl methacrylate, and N-butoxymethyl acrylamide and benzyl methacrylic and a copolymer of lactate and 2-hydroxypropyl methacrylate.

본 발명에 이용하는 (B)성분인 폴리머를 얻는 방법은 특별히 한정되지 않으나, 예를 들어, N-알콕시메틸(메트)아크릴아미드 화합물과 필요에 따라 공중합가능한 모노머와 중합개시제 등을 공존시킨 용제 중에 있어서, 50 내지 110℃의 온도하에서 중합반응시킴으로써 얻어진다. 그 때, 이용되는 용제는, N-알콕시메틸(메트)아크릴아미드 화합물, 필요에 따라 공중합가능한 모노머 및 중합개시제 등을 용해하는 것이면 특별히 한정되지 않는다. 구체예로는, 후술하는 <용제>에 기재한다.The method for obtaining the polymer as component (B) used in the present invention is not particularly limited, but for example, in a solvent in which an N-alkoxymethyl (meth)acrylamide compound, a copolymerizable monomer and a polymerization initiator, etc. are coexisted as needed. , obtained by polymerization at a temperature of 50 to 110 °C. In that case, the solvent used will not be specifically limited if it dissolves an N-alkoxy methyl (meth)acrylamide compound, a copolymerizable monomer, a polymerization initiator, etc. as needed. As a specific example, it describes in the <solvent> mentioned later.

상기 방법에 의해 얻어지는 폴리머는, 통상, 용제에 용해된 용액의 상태이다.The polymer obtained by the said method is the state of the solution melt|dissolved in the solvent normally.

또한, 상기 방법으로 얻어진 폴리머의 용액을, 교반 중의 디에틸에테르나 물 등에 투입하여 침전시키고, 생성된 침전물을 여과·세정한 후에, 상압 또는 감압하에서, 상온건조 또는 가열건조하고, 폴리머의 분체(粉體)로 할 수 있다. 상기 조작에 의해, 폴리머와 공존하는 중합개시제 및 미반응의 모노머를 제거할 수 있고, 그 결과, 정제한 폴리머의 분체가 얻어진다. 한번의 조작으로 충분히 정제할 수 없는 경우는, 얻어진 분체를 용제에 재용해시켜, 상기의 조작을 반복 행하면 된다.In addition, the polymer solution obtained by the above method is poured into diethyl ether or water while stirring to precipitate, and the resulting precipitate is filtered and washed, then dried at room temperature or heat-dried under normal pressure or reduced pressure, and polymer powder (粉体) can be done. By the above operation, the polymerization initiator and unreacted monomer coexisting with the polymer can be removed, and as a result, a purified polymer powder is obtained. What is necessary is just to make the obtained powder re-dissolve in a solvent again, and just to perform said operation repeatedly, when refinement|purification cannot fully be carried out by one operation.

본 발명에 있어서는, (B)성분인 폴리머는 분체형태로, 혹은 정제한 분말을 후술하는 용제에 재용해한 용액형태로 이용할 수도 있다.In this invention, the polymer which is (B) component can also be used in the form of a powder or the form of the solution which melt|dissolved the refined powder again in the solvent mentioned later.

또한, 본 발명에 있어서는, (B)성분인 폴리머는, 복수종의 폴리머의 혼합물일 수도 있다.In addition, in this invention, the mixture of several types of polymers may be sufficient as the polymer which is (B) component.

본 발명에 있어서, (B)성분인 폴리머를 제조할 때에 상기의 공중합가능한 모노머를 이용하는 경우는, 이 공중합가능한 모노머의 사용량은, (B)성분의 폴리머를 제조하는데 이용하는 모노머의 몰수의 합계에 기초하여, 바람직하게는 1몰% 내지 200몰%이고, 보다 바람직하게는 10%몰 내지 100몰%이다.In the present invention, when the above-mentioned copolymerizable monomer is used for producing the polymer as component (B), the amount of the copolymerizable monomer used is based on the total number of moles of the monomer used for preparing the polymer of component (B). Therefore, it is preferably 1 mol% to 200 mol%, and more preferably 10% to 100 mol%.

이러한 (B)성분인 폴리머의 중량평균분자량은, 1,000 내지 500,000이고, 바람직하게는, 2,000 내지 200,000이고, 보다 바람직하게는 3,000 내지 150,000이고, 더욱 바람직하게는 3,000 내지 50,000이다. 한편, 중량평균분자량은, 겔퍼미에이션크로마토그래피(GPC)에 의해, 표준시료로서 폴리스티렌을 이용하여 얻어지는 값이다.The weight average molecular weight of the polymer which is such (B) component is 1,000-500,000, Preferably, it is 2,000-200,000, More preferably, it is 3,000-150,000, More preferably, it is 3,000-50,000. On the other hand, the weight average molecular weight is a value obtained using polystyrene as a standard sample by gel permeation chromatography (GPC).

이들 (B)성분의 폴리머는, 단독으로 또는 2종 이상을 조합하여 사용할 수 있다.The polymer of these (B) component can be used individually or in combination of 2 or more type.

<(C)성분><(C)component>

(C)성분은, 적어도 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머이다. 한편, N-하이드록시알킬(메트)아크릴아미드란, N-하이드록시알킬아크릴아미드와 N-하이드록시알킬메타크릴아미드의 쌍방을 의미한다.(C) A component is a polymer formed by polymerizing the monomer containing at least an N-hydroxyalkyl (meth)acrylamide compound. In addition, N-hydroxyalkyl (meth)acrylamide means both N-hydroxyalkyl acrylamide and N-hydroxyalkyl methacrylamide.

본 발명의 조성물을 도막으로 하여 열경화시켰을 때에, (B)성분의 N-알콕시메틸기와, (C)성분의 하이드록시기가 반응하여, 결합을 형성한다. 이에 따라, 도막이 강고해지고, 용제내성을 획득하게 된다.When thermosetting the composition of this invention as a coating film, the N-alkoxymethyl group of (B)component and the hydroxyl group of (C)component react, and a bond is formed. Thereby, the coating film becomes strong, and solvent resistance is acquired.

N-하이드록시알킬(메트)아크릴아미드 화합물로는, N-(2-하이드록시에틸)아크릴아미드, N-(2-하이드록시에틸)메타크릴아미드, N-(2-하이드록시프로필)아크릴아미드, N-(2-하이드록시프로필)메타크릴아미드, N-(4-하이드록시부틸)아크릴아미드, N-(4-하이드록시부틸)메타크릴아미드, N-(2,3-디하이드록시프로필)아크릴아미드, N-(2,3-디하이드록시프로필)메타크릴아미드 등을 들 수 있다.Examples of the N-hydroxyalkyl (meth)acrylamide compound include N-(2-hydroxyethyl)acrylamide, N-(2-hydroxyethyl)methacrylamide, and N-(2-hydroxypropyl)acrylamide. , N- (2-hydroxypropyl) methacrylamide, N- (4-hydroxybutyl) acrylamide, N- (4-hydroxybutyl) methacrylamide, N- (2,3-dihydroxypropyl ) acrylamide, N-(2,3-dihydroxypropyl) methacrylamide, etc. are mentioned.

본 발명에서는, (C)성분의 폴리머를 제조할 때에, 상기 N-하이드록시알킬(메트)아크릴아미드 화합물 이외의 모노머(이하 「기타 모노머」라고도 기재한다.)를 공중합시킬 수도 있다.In this invention, when manufacturing the polymer of (C)component, monomers other than the said N-hydroxyalkyl (meth)acrylamide compound (it also describes as "other monomers" below.) can also be copolymerized.

본 발명에 있어서, (C)성분인 폴리머를 제조할 때에 기타 모노머를 이용하는 경우는, 이 기타 모노머의 사용량은, (C)성분의 폴리머를 제조하는데 이용하는 모노머의 몰수의 합계에 기초하여, 바람직하게는 30몰% 내지 90몰%이고, 보다 바람직하게는 30%몰 내지 70몰%이다.In the present invention, in the case of using other monomers when producing the polymer that is the component (C), the usage amount of the other monomers is preferably based on the total number of moles of the monomers used for producing the polymer of the component (C). is 30 mol% to 90 mol%, more preferably 30% to 70 mol%.

기타 모노머로는, 예를 들어 공업적으로 입수할 수 있는 라디칼중합반응가능한 모노머를 들 수 있다.Examples of the other monomer include an industrially available monomer capable of radical polymerization.

기타 모노머의 구체예로는, 불포화카르본산, 아크릴산에스테르 화합물, 메타크릴산에스테르 화합물, 아미드기함유 모노머, 말레이미드 화합물, 아크릴로니트릴, 말레산 무수물, 스티렌 화합물 및 비닐 화합물 등을 들 수 있다.Specific examples of the other monomer include unsaturated carboxylic acid, acrylic acid ester compound, methacrylic acid ester compound, amide group-containing monomer, maleimide compound, acrylonitrile, maleic anhydride, styrene compound, and vinyl compound.

상기 불포화카르본산의 구체예로는 아크릴산, 메타크릴산, 이타콘산, 말레산, 푸마르산 등을 들 수 있다.Specific examples of the unsaturated carboxylic acid include acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and the like.

상기 아크릴산에스테르 화합물로는, 예를 들어, 메틸아크릴레이트, 에틸아크릴레이트, 이소프로필아크릴레이트, 벤질아크릴레이트, 나프틸아크릴레이트, 안트릴아크릴레이트, 안트릴메틸아크릴레이트, 페닐아크릴레이트, 2,2,2-트리플루오로에틸아크릴레이트, tert-부틸아크릴레이트, 시클로헥실아크릴레이트, 이소보닐아크릴레이트, 2-메톡시에틸아크릴레이트, 메톡시트리에틸렌글리콜아크릴레이트, 2-에톡시에틸아크릴레이트, 테트라하이드로푸르푸릴아크릴레이트, 3-메톡시부틸아크릴레이트, 2-메틸-2-아다만틸아크릴레이트, 2-프로필-2-아다만틸아크릴레이트, 8-메틸-8-트리시클로데실아크릴레이트, 2-하이드록시에틸아크릴레이트, 2-하이드록시프로필아크릴레이트, 4-하이드록시부틸아크릴레이트, 2,3-디하이드록시프로필아크릴레이트, 디에틸렌글리콜모노아크릴레이트, 카프로락톤2-(아크릴로일옥시)에틸에스테르, 폴리(에틸렌글리콜)에틸에테르아크릴레이트, 5-아크릴로일옥시-6-하이드록시노보넨-2-카르복실릭-6-락톤, 아크릴로일에틸이소시아네이트, 및, 8-에틸-8-트리시클로데실아크릴레이트, 글리시딜아크릴레이트 등을 들 수 있다.Examples of the acrylic acid ester compound include methyl acrylate, ethyl acrylate, isopropyl acrylate, benzyl acrylate, naphthyl acrylate, anthryl acrylate, anthryl methyl acrylate, phenyl acrylate, 2, 2,2-trifluoroethyl acrylate, tert-butyl acrylate, cyclohexyl acrylate, isobornyl acrylate, 2-methoxyethyl acrylate, methoxytriethylene glycol acrylate, 2-ethoxyethyl acrylate , tetrahydrofurfuryl acrylate, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2-adamantyl acrylate, 8-methyl-8-tricyclodecyl acrylic Rate, 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 4-hydroxybutyl acrylate, 2,3-dihydroxypropyl acrylate, diethylene glycol monoacrylate, caprolactone 2- (acrylic Royloxy) ethyl ester, poly (ethylene glycol) ethyl ether acrylate, 5-acryloyloxy-6-hydroxynorbornene-2-carboxylic-6-lactone, acryloylethyl isocyanate, and 8 -Ethyl-8-tricyclodecyl acrylate, glycidyl acrylate, etc. are mentioned.

상기 메타크릴산에스테르 화합물로는, 예를 들어, 메틸메타크릴레이트, 에틸메타크릴레이트, 이소프로필메타크릴레이트, 벤질메타크릴레이트, 나프틸메타크릴레이트, 안트릴메타크릴레이트, 안트릴메틸메타크릴레이트, 페닐메타크릴레이트, 2,2,2-트리플루오로에틸메타크릴레이트, tert-부틸메타크릴레이트, 시클로헥실메타크릴레이트, 이소보닐메타크릴레이트, 2-메톡시에틸메타크릴레이트, 메톡시트리에틸렌글리콜메타크릴레이트, 2-에톡시에틸메타크릴레이트, 테트라하이드로푸르푸릴메타크릴레이트, 3-메톡시부틸메타크릴레이트, 2-메틸-2-아다만틸메타크릴레이트, γ-부티로락톤메타크릴레이트, 2-프로필-2-아다만틸메타크릴레이트, 8-메틸-8-트리시클로데실메타크릴레이트, 2-하이드록시에틸메타크릴레이트, 2-하이드록시프로필메타크릴레이트, 4-하이드록시부틸메타크릴레이트, 2,3-디하이드록시프로필메타크릴레이트, 디에틸렌글리콜모노메타크릴레이트, 카프로락톤2-(메타크릴로일옥시)에틸에스테르, 폴리(에틸렌글리콜)에틸에테르메타크릴레이트, 5-메타크릴로일옥시-6-하이드록시노보넨-2-카르복실릭-6-락톤, 메타크릴로일에틸이소시아네이트, 및, 8-에틸-8-트리시클로데실메타크릴레이트, 글리시딜메타크릴레이트 등을 들 수 있다.Examples of the methacrylic acid ester compound include methyl methacrylate, ethyl methacrylate, isopropyl methacrylate, benzyl methacrylate, naphthyl methacrylate, anthryl methacrylate, anthryl methyl methacrylate. acrylate, phenyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, isobornyl methacrylate, 2-methoxyethyl methacrylate, Methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofurfuryl methacrylate, 3-methoxybutyl methacrylate, 2-methyl-2-adamantyl methacrylate, γ- Butyrolactone methacrylate, 2-propyl-2-adamantyl methacrylate, 8-methyl-8-tricyclodecyl methacrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate , 4-hydroxybutyl methacrylate, 2,3-dihydroxypropyl methacrylate, diethylene glycol monomethacrylate, caprolactone 2- (methacryloyloxy) ethyl ester, poly (ethylene glycol) ethyl Ether methacrylate, 5-methacryloyloxy-6-hydroxynorbornene-2-carboxylic-6-lactone, methacryloylethyl isocyanate, and 8-ethyl-8-tricyclodecylmethacrylic rate, glycidyl methacrylate, and the like.

상기 아미드기함유 모노머로는, N-비닐피롤리돈, N-비닐포름아미드, N-비닐아세트아미드, N-메틸(메트)아크릴아미드, N-에틸(메트)아크릴아미드, N-프로필(메트)아크릴아미드, N-부틸(메트)아크릴아미드, N-이소부틸(메트)아크릴아미드, N-헥실(메트)아크릴아미드, N-옥틸(메트)아크릴아미드, N-(메톡시메틸)(메트)아크릴아미드, N-(메톡시부틸)(메트)아크릴아미드, N-(에톡시메틸)(메트)아크릴아미드, N-(부톡시메틸)(메트)아크릴아미드, N-(이소부톡시메틸)(메트)아크릴아미드, N-(이소부톡시에틸)(메트)아크릴아미드, N-비닐프탈이미드, N-비닐석신산이미드 등을 들 수 있다.Examples of the amide group-containing monomer include N-vinylpyrrolidone, N-vinylformamide, N-vinylacetamide, N-methyl (meth)acrylamide, N-ethyl (meth)acrylamide, N-propyl (meth) ) acrylamide, N-butyl (meth) acrylamide, N-isobutyl (meth) acrylamide, N-hexyl (meth) acrylamide, N-octyl (meth) acrylamide, N- (methoxymethyl) (meth) ) acrylamide, N-(methoxybutyl)(meth)acrylamide, N-(ethoxymethyl)(meth)acrylamide, N-(butoxymethyl)(meth)acrylamide, N-(isobutoxymethyl) (meth)acrylamide, N-(isobutoxyethyl)(meth)acrylamide, N-vinylphthalimide, N-vinylsuccinimide, etc. are mentioned.

상기 비닐 화합물로는, 예를 들어, 비닐에테르, 메틸비닐에테르, 벤질비닐에테르, 비닐나프탈렌, 비닐안트라센, 비닐비페닐, 비닐카바졸, 2-하이드록시에틸비닐에테르, 페닐비닐에테르, 및, 프로필비닐에테르 등을 들 수 있다.Examples of the vinyl compound include vinyl ether, methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl anthracene, vinyl biphenyl, vinyl carbazole, 2-hydroxyethyl vinyl ether, phenyl vinyl ether, and propyl Vinyl ether etc. are mentioned.

상기 스티렌 화합물로는, 예를 들어, 스티렌, 메틸스티렌, 클로로스티렌, 브로모스티렌 등을 들 수 있다.As said styrene compound, styrene, methylstyrene, chlorostyrene, bromostyrene etc. are mentioned, for example.

상기 말레이미드 화합물로는, 예를 들어, 말레이미드, N-메틸말레이미드, N-페닐말레이미드, 및 N-시클로헥실말레이미드 등을 들 수 있다.As said maleimide compound, maleimide, N-methyl maleimide, N-phenyl maleimide, N-cyclohexyl maleimide, etc. are mentioned, for example.

상기 아크릴로니트릴 화합물로는, 예를 들어, 아크릴로니트릴 등을 들 수 있다.As said acrylonitrile compound, acrylonitrile etc. are mentioned, for example.

본 발명에 이용하는 (C)성분인 폴리머를 얻는 방법은 특별히 한정되지 않으나, 상기 (B)성분인 폴리머의 제조방법에 있어서, N-알콕시메틸(메트)아크릴아미드 화합물 대신에 N-하이드록시알킬(메트)아크릴아미드 화합물을 이용하면 된다.The method for obtaining the polymer as component (C) used in the present invention is not particularly limited, but in the method for producing the polymer as component (B), N-hydroxyalkyl ( A meth)acrylamide compound may be used.

이러한 (C)성분인 폴리머의 중량평균분자량은, 1,000 내지 500,000이고, 바람직하게는, 2,000 내지 200,000이고, 보다 바람직하게는 3,000 내지 150,000이고, 더욱 바람직하게는 3,000 내지 100,000이다. 한편, 중량평균분자량은, 겔퍼미에이션크로마토그래피(GPC)에 의해, 표준시료로서 폴리스티렌을 이용하여 얻어지는 값이다.The weight average molecular weight of the polymer which is such (C)component is 1,000-500,000, Preferably it is 2,000-200,000, More preferably, it is 3,000-150,000, More preferably, it is 3,000-100,000. On the other hand, the weight average molecular weight is a value obtained using polystyrene as a standard sample by gel permeation chromatography (GPC).

이들 (C)성분의 폴리머는, 단독으로 또는 2종 이상을 조합하여 사용할 수 있다.The polymer of these (C)component can be used individually or in combination of 2 or more type.

본 발명의 경화막 형성 조성물에 있어서의 (B)성분인 폴리머 및 (C)성분인 폴리머의 함유량으로는, (A)성분의 100질량부에 기초하여, (B)성분과 (C)성분의 합계량이 100 내지 3000질량부인 것이 바람직하고, 200 내지 2500질량부인 것이 더욱 바람직하고, 300 내지 2000질량부인 것이 특히 바람직하다.As content of the polymer which is (B) component in the cured film formation composition of this invention, and the polymer which is (C)component, based on 100 mass parts of (A) component, (B) component and (C)component It is preferable that a total amount is 100-3000 mass parts, It is more preferable that it is 200-2500 mass parts, It is especially preferable that it is 300-2000 mass parts.

또한, (B)성분과 (C)성분의 질량비는, 1:99 내지 99:1인 것이 바람직하고, 5:95 내지 95:5인 것이 더욱 바람직하고, 10:90 내지 90:10인 것이 특히 바람직하다.Moreover, it is preferable that mass ratio of (B)component and (C)component is 1:99-99:1, It is still more preferable that it is 5:95-95:5, It is especially that it is 10:90-90:10 desirable.

<(D)성분><(D)component>

본 발명의 경화막 형성 조성물은, (A)성분, (B)성분, (C)성분에 더하여, 추가로, (D)성분으로서 가교촉매를 함유할 수 있다.In addition to (A) component, (B) component, and (C)component, the cured film formation composition of this invention can contain a crosslinking catalyst as (D)component further.

(D)성분인 가교촉매로는, 예를 들어, 산 또는 열산발생제를 사용할 수 있다. 이 (D)성분은, 본 발명의 경화막 형성 조성물의 열경화반응을 촉진시키는데 있어서 유효하다.(D) As a crosslinking catalyst which is a component, an acid or a thermal acid generator can be used, for example. When this (D)component accelerates|stimulates the thermosetting reaction of the cured film formation composition of this invention, it is effective.

상기 산으로는, 설폰산기함유 화합물, 염산 또는 그의 염 등을 들 수 있다. 또한, 상기 열산발생제로는, 프리베이크 또는 포스트베이크시에 열분해되어 산을 발생하는 화합물, 즉 온도 80℃ 내지 250℃에서 열분해되어 산을 발생하는 화합물이면 특별히 한정되는 것은 아니다.Examples of the acid include a sulfonic acid group-containing compound, hydrochloric acid or a salt thereof. In addition, the thermal acid generator is not particularly limited as long as it is a compound that is thermally decomposed to generate an acid during pre-baking or post-baking, that is, a compound that is thermally decomposed at a temperature of 80°C to 250°C to generate an acid.

산으로는, 예를 들어, 염산 또는 그의 염; 메탄설폰산, 에탄설폰산, 프로판설폰산, 부탄설폰산, 펜탄설폰산, 옥탄설폰산, 벤젠설폰산, p-톨루엔설폰산, 캠퍼설폰산, 트리플루오로메탄설폰산, p-페놀설폰산, 2-나프탈렌설폰산, 메시틸렌설폰산, p-자일렌-2-설폰산, m-자일렌-2-설폰산, 4-에틸벤젠설폰산, 1H,1H,2H,2H-퍼플루오로옥탄설폰산, 퍼플루오로(2-에톡시에탄)설폰산, 펜타플루오로에탄설폰산, 노나플루오로부탄-1-설폰산, 도데실벤젠설폰산 등의 설폰산 또는 그의 수화물이나 염 등을 들 수 있다.The acid includes, for example, hydrochloric acid or a salt thereof; Methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid, pentanesulfonic acid, octanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, trifluoromethanesulfonic acid, p-phenolsulfonic acid , 2-naphthalenesulfonic acid, mesitylenesulfonic acid, p-xylene-2-sulfonic acid, m-xylene-2-sulfonic acid, 4-ethylbenzenesulfonic acid, 1H,1H,2H,2H-perfluoro Sulfonic acids such as octanesulfonic acid, perfluoro(2-ethoxyethane)sulfonic acid, pentafluoroethanesulfonic acid, nonafluorobutane-1-sulfonic acid, dodecylbenzenesulfonic acid, or hydrates or salts thereof can be heard

열에 의해 산을 발생하는 화합물로는, 예를 들어, 비스(토실옥시)에탄, 비스(토실옥시)프로판, 비스(토실옥시)부탄, p-니트로벤질토실레이트, o-니트로벤질토실레이트, 1,2,3-페닐렌트리스(메틸설포네이트), p-톨루엔설폰산피리디늄염, p-톨루엔설폰산모르포늄염, p-톨루엔설폰산에틸에스테르, p-톨루엔설폰산프로필에스테르, p-톨루엔설폰산부틸에스테르, p-톨루엔설폰산이소부틸에스테르, p-톨루엔설폰산메틸에스테르, p-톨루엔설폰산페네틸에스테르, 시아노메틸p-톨루엔설포네이트, 2,2,2-트리플루오로에틸p-톨루엔설포네이트, 2-하이드록시부틸p-톨루엔설포네이트, N-에틸-p-톨루엔설폰아미드, 및 하기 식으로 표시되는 화합물 등을 들 수 있다.As a compound which generates an acid by heat, for example, bis(tosyloxy)ethane, bis(tosyloxy)propane, bis(tosyloxy)butane, p-nitrobenzyltosylate, o-nitrobenzyltosylate, 1 ,2,3-phenylentris (methylsulfonate), p-toluenesulfonic acid pyridinium salt, p-toluenesulfonic acid morphonium salt, p-toluenesulfonic acid ethyl ester, p-toluenesulfonic acid propyl ester, p-toluenesulfonic acid Butyl ester, p-toluenesulfonic acid isobutyl ester, p-toluenesulfonic acid methyl ester, p-toluenesulfonic acid phenethyl ester, cyanomethyl p-toluenesulfonate, 2,2,2-trifluoroethyl p- toluenesulfonate, 2-hydroxybutylp-toluenesulfonate, N-ethyl-p-toluenesulfonamide, and a compound represented by the following formula; and the like.

[화학식 3][Formula 3]

Figure pct00003
Figure pct00003

[화학식 4][Formula 4]

Figure pct00004
Figure pct00004

[화학식 5][Formula 5]

Figure pct00005
Figure pct00005

[화학식 6][Formula 6]

Figure pct00006
Figure pct00006

[화학식 7][Formula 7]

Figure pct00007
Figure pct00007

[화학식 8][Formula 8]

Figure pct00008
Figure pct00008

본 발명의 경화막 형성 조성물에 있어서의 (D)성분의 함유량은, (B)성분의 폴리머와 (C)성분의 폴리머의 합계량 100질량부에 기초하여, 바람직하게는 0.01질량부 내지 10질량부이고, 보다 바람직하게는 0.1질량부 내지 6질량부이고, 더욱 바람직하게는 0.5질량부 내지 5질량부이다. (D)성분의 함유량을 0.01질량부 이상으로 함으로써, 충분한 열경화성 및 용제내성을 부여할 수 있고, 나아가 광조사에 대한 높은 감도도 부여할 수 있다. 그러나, 10질량부보다 많은 경우, 조성물의 보존안정성이 저하되는 경우가 있다.Preferably content of (D)component in the cured film formation composition of this invention is 0.01 mass part - 10 mass parts based on 100 mass parts of total amounts of the polymer of (B) component, and the polymer of (C)component and more preferably 0.1 parts by mass to 6 parts by mass, and still more preferably 0.5 parts by mass to 5 parts by mass. (D) By making content of a component into 0.01 mass part or more, sufficient thermosetting and solvent tolerance can be provided, and also the high sensitivity with respect to light irradiation can also be provided. However, when more than 10 mass parts, the storage stability of a composition may fall.

<(E)성분><(E) component>

본 발명의 경화막 형성 조성물은 (E)성분으로서, 형성되는 경화막의 밀착성을 향상시키는 성분(이하, 밀착향상성분이라고도 한다.)을 함유할 수도 있다.The cured film formation composition of this invention may contain the component (it is also hereafter called an adhesion improvement component.) which improves the adhesiveness of the cured film formed as (E) component.

(E)성분인 밀착향상성분은, 본 발명의 경화막 형성 조성물로부터 얻어지는 배향재와 중합성 액정의 층과의 밀착성이 향상되도록, 중합성 액정의 중합성 관능기와 배향재의 가교반응부위를 공유결합에 의해 링크시킬 수 있다. 그 결과, 본 실시형태의 배향재 상에 경화된 중합성 액정을 적층하여 이루어지는 본 실시형태의 위상차재는, 고온고질의 조건하에서도, 강한 밀착성을 유지할 수 있어, 박리 등에 대한 높은 내구성을 나타낼 수 있다.(E) The adhesion-improving component is a covalent bond between the polymerizable functional group of the polymerizable liquid crystal and the crosslinking reaction site of the alignment material so that the adhesion between the layer of the polymerizable liquid crystal and the alignment material obtained from the cured film forming composition of the present invention is improved. can be linked by As a result, the retardation material of this embodiment formed by laminating a cured polymerizable liquid crystal on the alignment material of this embodiment can maintain strong adhesiveness even under high-temperature and high-quality conditions, and can exhibit high durability against peeling etc. .

(E)성분으로는, 하이드록시기 및 N-알콕시메틸기로부터 선택되는 기와, 중합성기를 갖는 모노머 및 폴리머가 바람직하다.(E) As a component, the monomer and polymer which have group chosen from a hydroxyl group and N-alkoxy methyl group, and a polymeric group are preferable.

이러한 (E)성분으로는, 하이드록시기와 (메트)아크릴기를 갖는 화합물, N-알콕시메틸기와 (메트)아크릴기를 갖는 화합물, N-알콕시메틸기와 (메트)아크릴기를 갖는 폴리머 등을 들 수 있다. 이하, 각각 구체예를 나타낸다.As such component (E), the compound which has a hydroxyl group and a (meth)acryl group, the compound which has N-alkoxymethyl group and a (meth)acryl group, the polymer etc. which have an N-alkoxymethyl group and a (meth)acryl group are mentioned. Specific examples are shown below, respectively.

(E)성분의 일례로서, 하이드록시기를 함유한 다관능아크릴레이트(이하, 하이드록시기함유 다관능아크릴레이트라고도 한다.)를 들 수 있다.(E) As an example of a component, the polyfunctional acrylate containing a hydroxyl group (Hereinafter, it is also mentioned hydroxyl group containing polyfunctional acrylate.) is mentioned.

(E)성분의 예인 하이드록시기함유 다관능아크릴레이트로는, 예를 들어, 펜타에리스리톨트리아크릴레이트 및 디펜타에리스리톨펜타아크릴레이트 등을 들 수 있다.(E) As a hydroxyl-group containing polyfunctional acrylate which is an example of a component, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, etc. are mentioned, for example.

(E)성분의 일례로서, 1개의 (메트)아크릴기와, 1개 이상의 하이드록시기를 갖는 화합물도 들 수 있다.(E) As an example of a component, the compound which has one (meth)acryl group and one or more hydroxyl groups is also mentioned.

또한, (E)성분의 화합물로는, 1분자 중에 C=C이중결합을 포함하는 중합성기를 적어도 1개와, N-알콕시메틸기를 적어도 1개 갖는 화합물을 들 수 있다.Moreover, as a compound of (E)component, the compound which has at least one polymeric group containing a C=C double bond in 1 molecule, and at least one N-alkoxymethyl group is mentioned.

C=C이중결합을 포함하는 중합성기로는, 아크릴기, 메타크릴기, 비닐기, 알릴기, 말레이미드기 등을 들 수 있다.Examples of the polymerizable group containing a C=C double bond include an acryl group, a methacryl group, a vinyl group, an allyl group, and a maleimide group.

1분자 중에 C=C이중결합을 포함하는 중합성기를 적어도 1개와, N-알콕시메틸기를 적어도 1개 갖는 화합물로는, 바람직하게는, 예를 들어 하기의 식(X1)로 표시되는 화합물을 들 수 있다.As the compound having at least one polymerizable group containing a C=C double bond and at least one N-alkoxymethyl group in one molecule, preferably, for example, a compound represented by the following formula (X1) is exemplified can

[화학식 9][Formula 9]

Figure pct00009
Figure pct00009

(식 중, R31은 수소원자 또는 메틸기를 나타내고, R32는 수소원자, 또는 직쇄 혹은 분지의 탄소원자수 1 내지 10의 알킬기를 나타낸다)(Wherein, R 31 represents a hydrogen atom or a methyl group, and R 32 represents a hydrogen atom or a linear or branched alkyl group having 1 to 10 carbon atoms)

상기 탄소원자수 1 내지 10의 알킬기로는, 예를 들어, 메틸기, 에틸기, n-프로필기, 이소프로필기, n-부틸기, 이소부틸기, sec-부틸기, tert-부틸기, n-펜틸기, 1-메틸-n-부틸기, 2-메틸-n-부틸기, 3-메틸-n-부틸기, 1,1-디메틸-n-프로필기, 1,2-디메틸-n-프로필기, 2,2-디메틸-n-프로필기, 1-에틸-n-프로필기, n-헥실기, 1-메틸-n-펜틸기, 2-메틸-n-펜틸기, 3-메틸-n-펜틸기, 4-메틸-n-펜틸기, 1,1-디메틸-n-부틸기, 1,2-디메틸-n-부틸기, 1,3-디메틸-n-부틸기, 2,2-디메틸-n-부틸기, 2,3-디메틸-n-부틸기, 3,3-디메틸-n-부틸기, 1-에틸-n-부틸기, 2-에틸-n-부틸기, 1,1,2-트리메틸-n-프로필기, 1,2,2-트리메틸-n-프로필기, 1-에틸-1-메틸-n-프로필기, 1-에틸-2-메틸-n-프로필기, n-헵틸기, 1-메틸-n-헥실기, 2-메틸-n-헥실기, 3-메틸-n-헥실기, 1,1-디메틸-n-펜틸기, 1,2-디메틸-n-펜틸기, 1,3-디메틸-n-펜틸기, 2,2-디메틸-n-펜틸기, 2,3-디메틸-n-펜틸기, 3,3-디메틸-n-펜틸기, 1-에틸-n-펜틸기, 2-에틸-n-펜틸기, 3-에틸-n-펜틸기, 1-메틸-1-에틸-n-부틸기, 1-메틸-2-에틸-n-부틸기, 1-에틸-2-메틸-n-부틸기, 2-메틸-2-에틸-n-부틸기, 2-에틸-3-메틸-n-부틸기, n-옥틸기, 1-메틸-n-헵틸기, 2-메틸-n-헵틸기, 3-메틸-n-헵틸기, 1,1-디메틸-n-헥실기, 1,2-디메틸-n-헥실기, 1,3-디메틸-n-헥실기, 2,2-디메틸-n-헥실기, 2,3-디메틸-n-헥실기, 3,3-디메틸-n-헥실기, 1-에틸-n-헥실기, 2-에틸-n-헥실기, 3-에틸-n-헥실기, 1-메틸-1-에틸-n-펜틸기, 1-메틸-2-에틸-n-펜틸기, 1-메틸-3-에틸-n-펜틸기, 2-메틸-2-에틸-n-펜틸기, 2-메틸-3-에틸-n-펜틸기, 3-메틸-3-에틸-n-펜틸기, n-노닐기, n-데실기 등을 들 수 있다.Examples of the alkyl group having 1 to 10 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-pene Tyl group, 1-methyl-n-butyl group, 2-methyl-n-butyl group, 3-methyl-n-butyl group, 1,1-dimethyl-n-propyl group, 1,2-dimethyl-n-propyl group , 2,2-dimethyl-n-propyl group, 1-ethyl-n-propyl group, n-hexyl group, 1-methyl-n-pentyl group, 2-methyl-n-pentyl group, 3-methyl-n- Pentyl group, 4-methyl-n-pentyl group, 1,1-dimethyl-n-butyl group, 1,2-dimethyl-n-butyl group, 1,3-dimethyl-n-butyl group, 2,2-dimethyl -n-butyl group, 2,3-dimethyl-n-butyl group, 3,3-dimethyl-n-butyl group, 1-ethyl-n-butyl group, 2-ethyl-n-butyl group, 1,1, 2-trimethyl-n-propyl group, 1,2,2-trimethyl-n-propyl group, 1-ethyl-1-methyl-n-propyl group, 1-ethyl-2-methyl-n-propyl group, n- Heptyl group, 1-methyl-n-hexyl group, 2-methyl-n-hexyl group, 3-methyl-n-hexyl group, 1,1-dimethyl-n-pentyl group, 1,2-dimethyl-n-pene Tyl group, 1,3-dimethyl-n-pentyl group, 2,2-dimethyl-n-pentyl group, 2,3-dimethyl-n-pentyl group, 3,3-dimethyl-n-pentyl group, 1-ethyl- n-pentyl group, 2-ethyl-n-pentyl group, 3-ethyl-n-pentyl group, 1-methyl-1-ethyl-n-butyl group, 1-methyl-2-ethyl-n-butyl group, 1 -Ethyl-2-methyl-n-butyl group, 2-methyl-2-ethyl-n-butyl group, 2-ethyl-3-methyl-n-butyl group, n-octyl group, 1-methyl-n-hep group Tyl group, 2-methyl-n-heptyl group, 3-methyl-n-heptyl group, 1,1-dimethyl-n-hexyl group, 1,2-dimethyl-n-hexyl group, 1,3-dimethyl-n- Hexyl group, 2,2-dimethyl-n-hexyl group, 2,3-dimethyl-n-hexyl group, 3,3-dimethyl-n-hexyl group, 1-ethyl-n-hexyl group, 2-ethyl-n -Hexyl group, 3-ethyl-n-hexyl group, 1-methyl-1-ethyl-n-pentyl group, 1-methyl-2-ethyl-n-pentyl group, 1-methyl-3-ethyl-n-pene Tyl group, 2-methyl-2-ethyl-n-pentyl group, 2-methyl-3-ethyl-n-pentyl group, 3-methyl-3-ethyl-n-pentyl group, n-nonyl group, n-decyl group and the like.

상기 식(X1)로 표시되는 화합물의 구체예로는, N-하이드록시메틸(메트)아크릴아미드, N-메톡시메틸(메트)아크릴아미드, N-에톡시메틸(메트)아크릴아미드, N-부톡시메틸(메트)아크릴아미드 등의 하이드록시메틸기 혹은 알콕시메틸기로 치환된 아크릴아미드 화합물 또는 메타크릴아미드 화합물을 들 수 있다. 한편 (메트)아크릴아미드란 메타크릴아미드와 아크릴아미드의 쌍방을 의미한다.Specific examples of the compound represented by the formula (X1) include N-hydroxymethyl (meth)acrylamide, N-methoxymethyl (meth)acrylamide, N-ethoxymethyl (meth)acrylamide, N- and acrylamide compounds or methacrylamide compounds substituted with hydroxymethyl groups or alkoxymethyl groups, such as butoxymethyl (meth)acrylamide. On the other hand, (meth)acrylamide means both methacrylamide and acrylamide.

(E)성분의 C=C이중결합을 포함하는 중합성기와 N-알콕시메틸기를 갖는 화합물의 다른 태양으로는, 바람직하게는, 예를 들어 하기의 화합물을 들 수 있다.(E) As another aspect of the compound which has a polymeric group and N-alkoxymethyl group containing C=C double bond of component, Preferably, the following compound is mentioned, for example.

[화학식 10][Formula 10]

Figure pct00010
Figure pct00010

본 발명의 경화막 형성 조성물에 있어서의 (E)성분의 함유량은, (A)성분인 저분자의 광배향성분의 100질량부에 기초하여, 바람직하게는 1질량부 내지 100질량부이고, 더욱 바람직하게는 5질량부 내지 70질량부이다.Content of (E) component in the cured film formation composition of this invention is based on 100 mass parts of the low molecular photo-alignment component which is (A) component, Preferably it is 1 mass part - 100 mass parts, More preferably Preferably, it is 5 mass parts - 70 mass parts.

<용제><solvent>

본 발명 경화막 형성 조성물은, 주로 용제에 용해된 용액상태로 이용된다. 그 때에 사용하는 용제는, (A)성분, (B)성분 및 (C)성분, 필요에 따라 (D)성분, (E)성분 및/또는 후술하는 기타 첨가제를 용해할 수 있으면 되며, 그 종류 및 구조 등은 특별히 한정되는 것이 아니다.The cured film formation composition of this invention is mainly used in the solution state melt|dissolved in the solvent. The solvent used in that case should just be able to melt|dissolve (A) component, (B) component, and (C)component, and (D)component, (E)component and/or other additives mentioned later as needed, the kind and structures are not particularly limited.

용제의 구체예로는, 예를 들어, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 프로필렌글리콜, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜프로필에테르아세테이트, 톨루엔, 자일렌, 메틸에틸케톤, 시클로펜탄온, 시클로헥사논, 2-부탄온, 3-메틸-2-펜탄온, 2-펜탄온, 2-헵탄온, γ-부티로락톤, 2-하이드록시프로피온산에틸, 2-하이드록시-2-메틸프로피온산에틸, 에톡시아세트산에틸, 하이드록시아세트산에틸, 2-하이드록시-3-메틸부탄산메틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산메틸, 피루브산메틸, 피루브산에틸, 아세트산에틸, 아세트산부틸, 유산에틸, 유산부틸, N,N-디메틸포름아미드, N,N-디메틸아세트아미드, 및 N-메틸피롤리돈 등을 들 수 있다. 이들 용제는, 1종 단독으로 또는 2종 이상의 조합으로 사용할 수 있다.As a specific example of a solvent, For example, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, propylene Glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2-pentane One, 2-pentanone, 2-heptanone, γ-butyrolactone, 2-hydroxyethyl propionate, 2-hydroxy-2-methylpropionate, ethyl ethoxyacetate, ethyl hydroxyacetate, 2-hydroxy Methyl -3-methylbutanoate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, ethyl 3-ethoxypropionate, methyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl acetate, butyl acetate, ethyl lactate , butyl lactate, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone. These solvents can be used individually by 1 type or in combination of 2 or more types.

<기타 첨가제><Other additives>

추가로, 본 발명의 경화막 형성 조성물은, 본 발명의 효과를 손상시키지 않는 한, 필요에 따라, 증감제, 실란커플링제, 계면활성제, 레올로지조정제, 안료, 염료, 보존안정제, 소포제, 산화방지제 등을 함유할 수 있다.Furthermore, the cured film formation composition of this invention is a sensitizer, a silane coupling agent, surfactant, a rheology adjusting agent, a pigment, dye, a storage stabilizer, an antifoaming agent, oxidation as needed, unless the effect of this invention is impaired. inhibitors, etc. may be contained.

예를 들어, 증감제는, 본 발명의 경화막 형성 조성물을 이용하여 열경화막을 형성한 후, 광반응을 촉진하는데 있어서 유효하다.For example, a sensitizer is effective in promoting a photoreaction, after forming a thermosetting film using the cured film formation composition of this invention.

기타 첨가제의 일례인 증감제로는, 벤조페논, 안트라센, 안트라퀴논, 티옥산톤 등 및 그의 유도체, 그리고 니트로페닐 화합물 등을 들 수 있다. 이들 중, 벤조페논 유도체 및 니트로페닐 화합물이 바람직하다. 바람직한 화합물의 구체예로서 N,N-디에틸아미노벤조페논, 2-니트로플루오렌, 2-니트로플루오레논, 5-니트로아세나프텐, 4-니트로비페닐, 4-니트로계피산, 4-니트로스틸벤, 4-니트로벤조페논, 5-니트로인돌 등을 들 수 있다. 특히, 벤조페논의 유도체인 N,N-디에틸아미노벤조페논이 바람직하다.As a sensitizer which is an example of another additive, benzophenone, anthracene, anthraquinone, thioxanthone, its derivative(s), a nitrophenyl compound, etc. are mentioned. Among these, a benzophenone derivative and a nitrophenyl compound are preferable. Specific examples of preferred compounds include N,N-diethylaminobenzophenone, 2-nitrofluorene, 2-nitrofluorenone, 5-nitroacenaphthene, 4-nitrobiphenyl, 4-nitrocinnamic acid, 4-nitrostilbene, 4-nitrobenzophenone, 5-nitroindole, etc. are mentioned. In particular, N,N-diethylaminobenzophenone, which is a derivative of benzophenone, is preferable.

이들 증감제는 상기의 것으로 한정되는 것은 아니다. 또한, 증감제는 단독으로 또는 2종 이상의 화합물을 조합하여 사용하는 것이 가능하다.These sensitizers are not limited to said thing. In addition, it is possible to use a sensitizer individually or in combination of 2 or more types of compounds.

본 발명의 경화막 형성 조성물에 있어서의 증감제의 사용비율은, (A)성분의 저분자의 광배향성분의 100질량부에 기초하여, 0.1질량부 내지 20질량부인 것이 바람직하고, 보다 바람직하게는 0.2질량부 내지 10질량부이다. 이 비율이 과소한 경우에는, 증감제로서의 효과를 충분히 얻지 못하는 경우가 있고, 과대한 경우에는 투과율의 저하 및 도막이 거칠어지는 경우가 있다.It is preferable that the usage-rate of the sensitizer in the cured film formation composition of this invention is 0.1 mass part - 20 mass parts based on 100 mass parts of the low molecular photo-alignment component of (A) component, More preferably It is 0.2 mass part - 10 mass parts. When this ratio is too little, the effect as a sensitizer may not fully be acquired, and when excessive, the transmittance|permeability may fall and a coating film may become rough.

<경화막 형성 조성물의 조제><Preparation of a cured film formation composition>

본 실시의 형태의 경화막 형성 조성물은, (A)성분인 저분자의 광배향성분과, (B)성분인 적어도 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머와, (C)성분인 적어도 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머를 함유한다. 그리고, 필요에 따라 (D)성분인 가교촉매, (E)성분인 밀착성향상성분 및/또는 기타 첨가제를 함유할 수 있다.The cured film forming composition of the present embodiment comprises a polymer formed by polymerizing a monomer containing at least an N-alkoxymethyl (meth)acrylamide compound as the component (A) and a low-molecular photo-alignment component as the component (B), ( C) The polymer formed by polymerizing the monomer containing at least N-hydroxyalkyl (meth)acrylamide compound as a component is contained. And, if necessary, the crosslinking catalyst as component (D), the adhesion improving component as component (E) and/or other additives may be contained.

본 발명의 경화막 형성 조성물을 용액으로서 이용하는 경우의 배합비율, 조제방법 등을 이하에 상술한다.The compounding ratio in the case of using the cured film formation composition of this invention as a solution, a preparation method, etc. are explained in full detail below.

본 발명의 경화막 형성 조성물에 있어서의 고형분의 비율은, 각 성분이 균일하게 용제에 용해되어 있는 한, 특별히 한정되는 것은 아니나, 1질량% 내지 80질량%이고, 바람직하게는 3질량% 내지 60질량%이고, 보다 바람직하게는 5질량% 내지 40질량%이다. 여기서, 고형분이란, 경화막 형성 조성물의 전체성분에서 용제를 제외한 것을 말한다.Although the ratio of solid content in the cured film formation composition of this invention is not specifically limited as long as each component is melt|dissolving in the solvent uniformly, It is 1 mass % - 80 mass %, Preferably it is 3 mass % - 60 It is mass %, More preferably, it is 5 mass % - 40 mass %. Here, solid content means what removed the solvent from all the components of a cured film formation composition.

본 발명의 경화막 형성 조성물의 조제방법은, 특별히 한정되지 않는다. 조제법으로는, 예를 들어, 용제에 용해된 (B)성분의 용액에 (A)성분, (C)성분 및 필요에 따라 (D)성분, (E)성분을 소정의 비율로 혼합하여, 균일한 용액으로 하는 방법, 혹은, 이 조제법의 적당한 단계에 있어서, 필요에 따라 기타 첨가제를 추가로 첨가하여 혼합하는 방법을 들 수 있다.The preparation method of the cured film formation composition of this invention is not specifically limited. As a preparation method, (A) component, (C)component and as needed (D)component, (E)component are mixed in predetermined ratio with the solution of (B)component melt|dissolved in a solvent, for example, and it is uniform A method of preparing a single solution, or a method of mixing by adding other additives as necessary in an appropriate step of the preparation method is exemplified.

본 발명의 경화막 형성 조성물의 조제에 있어서는, 용제 중의 중합반응에 의해 얻어지는 폴리머용액을 그대로 사용할 수 있다. 이 경우, 예를 들어, (C)성분의 용액에 (A)성분, (B)성분 및 필요에 따라 (D)성분, (E)성분을 넣어 균일한 용액으로 한다. 이때에, 농도조정을 목적으로 더 용제를 추가투입할 수도 있다. 이때, (C)성분의 생성과정에서 이용되는 용제와, 경화막 형성 조성물의 농도조정에 이용되는 용제는 동일할 수도 있고, 또한 상이할 수도 있다.In preparation of the cured film formation composition of this invention, the polymer solution obtained by the polymerization reaction in a solvent can be used as it is. In this case, for example, (C)component (A)component and (B)component and (D)component and (E)component are put into the solution of (C)component as needed, and it is set as a uniform solution. At this time, a solvent may be additionally added for the purpose of adjusting the concentration. At this time, the solvent used in the production|generation process of (C)component and the solvent used for density|concentration adjustment of a cured film formation composition may be the same, and may differ.

또한, 조제된 경화막 형성 조성물의 용액은, 구멍직경이 0.2μm 정도인 필터 등을 이용하여 여과한 후, 사용하는 것이 바람직하다.Moreover, it is preferable to use, after filtering the solution of the prepared cured film formation composition using the filter etc. whose pore diameter is about 0.2 micrometer.

<경화막, 배향재 및 위상차재><Cured film, alignment material and phase difference material>

본 발명의 경화막 형성 조성물의 용액을 기판(예를 들어, 실리콘/이산화실리콘피복기판, 실리콘나이트라이드기판, 금속, 예를 들어, 알루미늄, 몰리브덴, 크롬 등이 피복된 기판, 유리기판, 석영기판, ITO기판 등)이나 필름(예를 들어, 트리아세틸셀룰로오스(TAC)필름, 시클로올레핀폴리머필름, 폴리에틸렌테레프탈레이트필름, 아크릴필름 등의 수지필름) 등의 위에, 바코트, 회전도포, 흘림도포, 롤도포, 슬릿도포, 슬릿에 이은 회전도포, 잉크젯도포, 인쇄 등에 의해 도포하여 도막을 형성하고, 그 후, 핫플레이트 또는 오븐 등에서 가열건조함으로써, 경화막을 형성할 수 있다.A solution of the cured film forming composition of the present invention is applied to a substrate (eg, a silicon/silicon dioxide coated substrate, a silicon nitride substrate, a metal, for example, a substrate coated with aluminum, molybdenum, chromium, etc., a substrate, a glass substrate, a quartz substrate) , ITO substrate, etc.) or film (e.g., triacetyl cellulose (TAC) film, cycloolefin polymer film, polyethylene terephthalate film, resin film such as acrylic film), bar coat, spin coating, drip coating, A cured film can be formed by roll application, slit application, rotational application following the slit, inkjet application, printing, etc. to form a coating film, and then drying by heating on a hot plate or oven or the like.

가열건조의 조건으로는, 경화막으로부터 형성되는 배향재의 성분이, 그 위에 도포되는 중합성 액정용액에 용출되지 않을 정도로, 가교제에 의한 가교반응이 진행되면 되며, 예를 들어, 온도 60℃ 내지 200℃, 시간 0.4분간 내지 60분간의 범위 내에서 적당히 선택된 가열온도 및 가열시간이 채용된다. 가열온도 및 가열시간은, 바람직하게는 70℃ 내지 160℃, 0.5분간 내지 10분간이다.As the conditions for drying by heat, the crosslinking reaction by the crosslinking agent should proceed to such an extent that the component of the alignment material formed from the cured film does not elute to the polymerizable liquid crystal solution applied thereon, for example, at a temperature of 60°C to 200°C. A heating temperature and heating time appropriately selected within the range of from 0.4 minutes to 60 minutes are employed. The heating temperature and the heating time are preferably 70°C to 160°C, 0.5 minutes to 10 minutes.

본 발명의 경화막 형성 조성물을 이용하여 형성되는 경화막의 막두께는, 예를 들어, 0.05μm 내지 5μm이고, 사용하는 기판의 단차나 광학적, 전기적 성질을 고려하여 적당히 선택할 수 있다.The film thickness of the cured film formed using the cured film formation composition of this invention is 0.05 micrometer - 5 micrometers, for example, Considering the level|step difference of the board|substrate to be used, and an optical and electrical property, it can select suitably.

이렇게 하여 형성된 경화막은, 편광UV조사를 행함으로써 배향재, 즉, 액정 등의 액정성을 갖는 화합물을 배향시키는 부재로서 기능시킬 수 있다.The cured film formed in this way can function as an orientation material, ie, a member which orientates the compound which has liquid crystals, such as a liquid crystal, by performing polarization|polarized-light UV irradiation.

편광UV의 조사방법으로는, 통상 150nm 내지 450nm의 파장의 자외광 내지 가시광이 이용되며, 실온 또는 가열한 상태에서 수직 또는 경사방향으로부터 직선편광을 조사함으로써 행해진다.As a method of irradiating polarized UV, usually, ultraviolet light or visible light having a wavelength of 150 nm to 450 nm is used, and it is carried out by irradiating linearly polarized light from a vertical or oblique direction at room temperature or in a heated state.

본 발명의 경화막 형성 조성물로부터 형성된 배향재는 내용제성 및 내열성을 갖고 있으므로, 이 배향재 상에, 중합성 액정용액으로 이루어지는 위상차재료를 도포한 후, 액정의 상전이온도까지 가열함으로써 위상차재료를 액정상태로 하고, 배향재 상에서 배향시킨다. 그리고, 배향상태가 된 위상차재료를 그대로 경화시킴으로써, 광학이방성을 갖는 층으로서 위상차재를 형성할 수 있다.Since the alignment material formed from the cured film forming composition of the present invention has solvent resistance and heat resistance, a phase difference material made of a polymerizable liquid crystal solution is applied on the alignment material, and then the phase difference material is heated to the phase transition temperature of the liquid crystal to bring the phase difference material into a liquid crystal state. and oriented on the orientation material. And by hardening the retardation material which became an orientation state as it is, the retardation material can be formed as a layer which has optical anisotropy.

위상차재료로는, 예를 들어, 중합성기를 갖는 액정모노머 및 그것을 함유하는 조성물 등이 이용된다. 그리고, 배향재를 형성하는 기판이 필름인 경우에는, 본 발명의 위상차재를 갖는 필름은, 위상차필름으로서 유용하다. 이러한 위상차재를 형성하는 위상차재료는, 액정상태가 되어, 배향재 상에서, 수평배향, 콜레스테릭배향, 수직배향, 하이브리드배향 등의 배향상태를 취하는 것이 있으며, 각각 필요시되는 위상차에 따라 구분하여 사용할 수 있다.As the retardation material, for example, a liquid crystal monomer having a polymerizable group and a composition containing the same are used. And when the board|substrate which forms an orientation material is a film, the film which has the retardation material of this invention is useful as retardation film. The retardation material forming such a retardation material is in a liquid crystal state, and there are some that take an orientation state such as horizontal orientation, cholesteric orientation, vertical orientation, hybrid orientation, etc. on the orientation material. can be used

또한, 3D디스플레이에 이용되는 패턴화 위상차재를 제조하는 경우에는, 본 발명의 경화막 형성 조성물로부터 상기한 방법으로 형성된 경화막에, 라인앤스페이스패턴의 마스크를 개재하여 소정의 기준으로부터, 예를 들어, +45도의 방향으로 편광UV노광하고, 이어서, 마스크를 분리하고 나서 -45도의 방향으로 편광UV를 노광하여, 액정의 배향제어방향이 상이한 2종류의 액정배향영역이 형성된 배향재를 얻는다. 그 후, 중합성 액정용액으로 이루어지는 위상차재료를 도포한 후, 액정의 상전이온도까지 가열함으로써 위상차재료를 액정상태로 하고, 배향재 상에서 배향시킨다. 그리고, 배향상태가 된 위상차재료를 그대로 경화시켜, 위상차특성이 상이한 2종류의 위상차영역이 각각 복수, 규칙적으로 배치된, 패턴화 위상차재를 얻을 수 있다.In addition, in the case of manufacturing the patterned retardation material used for 3D display, from the cured film forming composition of the present invention to the cured film formed by the above method, through a mask of a line and space pattern, from a predetermined standard, for example For example, polarized UV exposure is carried out in a direction of +45 degrees, and then, after removing the mask, polarized UV exposure is exposed in a direction of -45 degrees to obtain an alignment material in which two types of liquid crystal alignment regions having different orientation control directions of liquid crystals are formed. Then, after apply|coating the retardation material which consists of a polymeric liquid crystal solution, by heating to the phase transition temperature of a liquid crystal, the retardation material is made into a liquid crystal state, and it is oriented on an alignment material. And by hardening the retardation material which has become an orientation state as it is, the patterned retardation material in which two types of retardation areas from which retardation characteristics differ are each arrange|positioned regularly and plural can be obtained.

또한, 상기와 같이 하여 형성된, 본 발명의 배향재를 갖는 2매의 기판을 이용하고, 스페이서를 개재하여 양 기판 상의 배향재가 서로 마주하도록 맞붙힌 후, 그들 기판 사이에 액정을 주입하여, 액정이 배향한 액정표시소자로 할 수도 있다.In addition, using two substrates having the alignment material of the present invention formed as described above, and bonding the alignment materials on both substrates to face each other through a spacer, liquid crystal is injected between the substrates, so that the liquid crystal is It can also be set as the liquid crystal display element which aligned.

이처럼, 본 발명의 경화막 형성 조성물은, 각종 위상차재(위상차필름)나 액정표시소자 등의 제조에 호적하게 이용할 수 있다.Thus, the cured film formation composition of this invention can be used suitably for manufacture of various retardation materials (retardation film), a liquid crystal display element, etc.

실시예Example

이하, 본 발명의 실시예를 들어, 본 발명을 구체적으로 설명하나, 본 발명은 이것들로 한정하여 해석되는 것은 아니다.Hereinafter, the present invention will be specifically described by way of examples of the present invention, but the present invention should not be construed as being limited thereto.

[실시예에서 이용하는 약기호][Abbreviations used in the examples]

이하의 실시예에서 이용하는 약기호의 의미는, 다음과 같다.The meanings of the abbreviations used in the following examples are as follows.

<원료><Raw material>

BMAA: N-부톡시메틸아크릴아미드BMAA: N-butoxymethylacrylamide

AIBN: α,α’-아조비스이소부티로니트릴AIBN: α,α'-azobisisobutyronitrile

MMA: 메틸메타크릴레이트MMA: methyl methacrylate

HEAA: N-(2-하이드록시에틸)아크릴아미드HEAA: N-(2-hydroxyethyl)acrylamide

MAIB: 디메틸2,2-아조비스이소부티레이트MAIB: Dimethyl 2,2-azobisisobutyrate

<A성분><Component A>

MCA: 4-메톡시계피산MCA: 4-methoxycinnamic acid

[화학식 11][Formula 11]

Figure pct00011
Figure pct00011

<B성분><Component B>

PB-1: 하기의 구조식으로 표시된다.PB-1: It is represented by the following structural formula.

[화학식 12][Formula 12]

Figure pct00012
Figure pct00012

<C성분><C component>

PC-1: 하기의 구조식으로 표시된다.PC-1: It is represented by the following structural formula.

[화학식 13][Formula 13]

Figure pct00013
Figure pct00013

PC-2: 하기의 구조식으로 표시된다.PC-2: It is represented by the following structural formula.

[화학식 14][Formula 14]

Figure pct00014
Figure pct00014

<D성분><Component D>

PTSA: p-톨루엔설폰산·일수화물PTSA: p-toluenesulfonic acid monohydrate

<E성분><E component>

E-1: 하기의 구조식으로 표시되는 N-알콕시메틸기 및 아크릴기를 갖는 화합물E-1: A compound having an N-alkoxymethyl group and an acryl group represented by the following structural formula

[화학식 15][Formula 15]

Figure pct00015
Figure pct00015

<용제><solvent>

실시예 및 비교예의 각 수지 조성물은 용제를 함유하고, 그의 용제로서, 프로필렌글리콜모노메틸에테르(PM), 아세트산부틸(BA)을 이용하였다.Each resin composition of an Example and a comparative example contained a solvent, and propylene glycol monomethyl ether (PM) and butyl acetate (BA) were used as the solvent.

<중합체의 분자량의 측정><Measurement of molecular weight of polymer>

중합예에 있어서의 아크릴공중합체의 분자량은, 토소(주)사제 겔침투크로마토그래피(GPC)장치(HLC-8320), 토소(주)사제 컬럼사제 컬럼(TSKgel ALPHA4000, TSKgel ALPHA3000)을 이용하고 이하와 같이 하여 측정하였다.For the molecular weight of the acrylic copolymer in the polymerization example, a gel permeation chromatography (GPC) apparatus (HLC-8320) manufactured by Tosoh Corporation, and a column manufactured by Tosoh Corporation (TSKgel ALPHA4000, TSKgel ALPHA3000) were used, and the following were used. It was measured in the same way.

한편, 하기의 수평균분자량(이하, Mn이라 칭한다.) 및 중량평균분자량(이하, Mw라 칭한다.)은, 폴리스티렌환산값으로 나타내었다.In addition, the following number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) are expressed in terms of polystyrene.

컬럼온도: 40℃Column temperature: 40℃

용리액: 테트라하이드로푸란Eluent: tetrahydrofuran

유속: 1.0mL/분Flow rate: 1.0 mL/min

검량선작성용 표준샘플: 토소(주)사제 표준폴리스티렌(분자량 427,000, 190,000, 37,900, 18,100, 5,970, 2,420, 1,010)Standard sample for calibration curve: standard polystyrene manufactured by Toso Corporation (molecular weights 427,000, 190,000, 37,900, 18,100, 5,970, 2,420, 1,010)

<B성분의 합성><Synthesis of component B>

<중합예-1><Polymerization Example-1>

BMAA 100.0g, 중합촉매로서 AIBN 1.0g을 PM 193.5g에 용해하고, 80℃에서 20시간 반응시킴으로써 아크릴중합체용액을 얻었다. 얻어진 아크릴중합체의 Mn은 10,000, Mw는 23,000이었다. 아크릴중합체용액을 헥산 2000.0g에 서서히 적하하여 고체를 석출시키고, 여과 및 감압건조함으로써, 중합체(PB-1)를 얻었다.An acrylic polymer solution was obtained by dissolving 100.0 g of BMAA and 1.0 g of AIBN as a polymerization catalyst in 193.5 g of PM, and reacting at 80° C. for 20 hours. Mn of the obtained acrylic polymer was 10,000, and Mw was 23,000. The acrylic polymer solution was gradually added dropwise to 2000.0 g of hexane to precipitate a solid, filtered and dried under reduced pressure to obtain a polymer (PB-1).

<C성분의 합성><Synthesis of C component>

<중합예-2><Polymerization Example-2>

MMA 7.0g, HEAA 5.8g, 중합촉매로서 MAIB 0.23g을 PM 13.0g에 용해하였다. 미리 4구 플라스크에 PM 6.50g을 첨가하여 85℃로 가열해 둔 적하조에 용해한 용액을 3시간에 걸쳐 적하하고, 환류하에서 3시간 반응시킴으로써 아크릴중합체용액을 얻었다. 얻어진 아크릴중합체의 Mn은 12,600, Mw는 43,100이었다. 목적의 중합체(PC-1) 40%PM용액을 얻었다.7.0 g of MMA, 5.8 g of HEAA, and 0.23 g of MAIB as a polymerization catalyst were dissolved in 13.0 g of PM. An acrylic polymer solution was obtained by adding a solution in which 6.50 g of PM was previously added to a four-neck flask and dissolved in a dropping tank heated to 85°C over 3 hours, followed by reacting under reflux for 3 hours. Mn of the obtained acrylic polymer was 12,600, and Mw was 43,100. A 40% PM solution of the target polymer (PC-1) was obtained.

<C성분의 합성><Synthesis of C component>

<중합예-3><Polymerization Example-3>

BMAA 47.10g, HEAA 34.5g, 중합촉매로서 MAIB 0.829g을 PM 82.50g에 용해하였다. 미리 4구 플라스크에 PM 41.25g을 첨가하여 85℃로 가열해 둔 적하조에 용해한 용액을 3시간에 걸쳐 적하하고, 적하 후 5시간 반응시킴으로써 아크릴중합체용액을 얻었다. 얻어진 아크릴중합체의 Mn은 6,500, Mw는 17,000이었다. 목적의 중합체(PC-2) 40%PM용액을 얻었다.47.10 g of BMAA, 34.5 g of HEAA, and 0.829 g of MAIB as a polymerization catalyst were dissolved in 82.50 g of PM. An acrylic polymer solution was obtained by adding 41.25 g of PM to a four-neck flask in advance and dissolving it in a dropping tank heated to 85°C over 3 hours, and then reacting for 5 hours after the dropwise addition. Mn of the obtained acrylic polymer was 6,500, and Mw was 17,000. A 40% PM solution of the target polymer (PC-2) was obtained.

<액정배향제(경화막 형성 조성물)의 조제><Preparation of liquid crystal aligning agent (cured film forming composition)>

<조제예 1><Preparation Example 1>

(A)성분으로서 MCA 0.079g, (B)성분으로서 중합예-1에서 얻은 PB-1 0.66g, (C)성분으로서 중합예-2에서 얻은 중합체(PC-1)의 40%PM용액을 0.26g, (E)성분으로서 E-1 0.056g(쥰세이화학(주)사제 94.6%BA용액), (D)성분으로서 PTSA 0.021g을 혼합하고, 이것에 용매로서의 PM 6.65g, BA 1.62g을 첨가하여 1시간 교반하고, 육안으로 용해된 것을 확인하여 용액을 얻었다. 이어서, 이 얻어진 용액을 구멍직경 0.2μm의 필터로 여과함으로써, 액정배향제(A-1)를 조제하였다.(A) 0.079 g of MCA as component, 0.66 g of PB-1 obtained in polymerization example-1 as (B) component, and 0.26 40% PM solution of the polymer (PC-1) obtained in polymerization example-2 as (C) component g, 0.056 g of E-1 (94.6% BA solution manufactured by Junsei Chemical Co., Ltd.) as component (E), 0.021 g of PTSA as component (D), and 6.65 g of PM as a solvent and 1.62 g of BA are added thereto After stirring for 1 hour, it was confirmed that the solution was dissolved visually to obtain a solution. Next, the liquid crystal aligning agent (A-1) was prepared by filtering this obtained solution with the filter with a pore diameter of 0.2 micrometer.

<조제예 2~6><Preparation Examples 2 to 6>

하기 표 1에 나타내는 종류 및 배합량의 각 성분을 이용한 것 이외는, 조제예 1과 동일하게 조작하여, 각 액정배향제(A-2)~(A-4), (B-1), (B-2)를 조제하였다.Except having used each component of the kind and compounding quantity shown in following Table 1, it operated similarly to Preparation Example 1, and each liquid crystal aligning agent (A-2) - (A-4), (B-1), (B -2) was prepared.

[표 1][Table 1]

Figure pct00016
Figure pct00016

APEPO-1: RFK-505(카와사키화성공업주식회사제)APEPO-1: RFK-505 (manufactured by Kawasaki Chemical Industry Co., Ltd.)

PEPO-1: 폴리라이트8651(DIC주식회사제)PEPO-1: Polylite 8651 (manufactured by DIC Corporation)

<수평배향용 중합성 액정용액의 제작><Preparation of polymerizable liquid crystal solution for horizontal alignment>

<제작예 1><Production Example 1>

수평배향용 중합성 액정인 LC-242 1.57g(BASF사제), 광라디칼개시제인 Irgacure907 0.047g(BASF사제), 레벨링재인 BYK-361N 0.008g을 첨가하고, 다시 용매로서 N-메틸피롤리돈(NMP) 6.55g, 시클로펜탄온 9.83g을 첨가하고, 2시간 교반하고 육안으로 용해되어 있는 것을 확인하여, 9질량%의 중합성 액정용액LC-1을 얻었다.1.57 g of LC-242 (manufactured by BASF), a polymerizable liquid crystal for horizontal alignment, 0.047 g of Irgacure907 (manufactured by BASF), a photo-radical initiator, and 0.008 g of BYK-361N, a leveling material, were added as a solvent, and N-methylpyrrolidone ( NMP) 6.55 g and cyclopentanone 9.83 g were added, it stirred for 2 hours, it confirmed that it was melt|dissolving visually, and 9 mass % polymeric liquid crystal solution LC-1 was obtained.

<액정배향막의 형성 및 위상차필름의 제작><Formation of liquid crystal alignment film and production of retardation film>

<실시예 1><Example 1>

조제예 1에서 조제한 액정배향제(A-1)를 기판으로서의 트리아세틸셀룰로오스(TAC)필름 상에 바코터를 이용하여 Wet막두께 6μm로 도포하였다. 열순환식 오븐 내에서 130℃에서 2분간의 가열건조를 행하고, 필름 상에 경화막을 형성하였다. 이어서, 이 경화막 표면에 313nm의 직선편광을 10mJ/cm2의 노광량으로 수직으로 조사하여, 액정배향막을 형성하였다. 수평배향용 중합성 액정용액LC-1을, 바코터를 이용하여 상기 액정배향막 상에 Wet막두께 34μm로 도포하였다. 이어서, 오븐 내에서 120℃에서 2분간의 가열건조를 행한 후, 질소하, 365nm의 비편광을 300mJ/cm2의 노광량으로 수직으로 조사함으로써 중합성 액정을 경화시켜, 위상차필름을 제작하였다.The liquid crystal aligning agent (A-1) prepared in Preparation Example 1 was applied on a triacetyl cellulose (TAC) film as a substrate using a bar coater to a wet film thickness of 6 μm. Heat-drying was performed at 130 degreeC for 2 minute(s) in a thermal circulation type oven, and the cured film was formed on the film. Next, 313 nm linearly polarized light was vertically irradiated to the surface of this cured film with the exposure amount of 10 mJ/cm< 2 >, and the liquid crystal aligning film was formed. A polymerizable liquid crystal solution LC-1 for horizontal alignment was applied to the liquid crystal alignment layer with a wet film thickness of 34 μm using a bar coater. Then, after heating and drying at 120 ° C. for 2 minutes in an oven, under nitrogen, by irradiating a non-polarized light of 365 nm vertically at an exposure amount of 300 mJ/cm 2 to cure the polymerizable liquid crystal, a retardation film was produced.

<실시예 2~4><Examples 2 to 4>

액정배향제로서 (A-2)~(A-4)를 이용하고, 실시예 1과 동일한 조작으로 위상차필름을 제작하였다.Using (A-2) to (A-4) as a liquid crystal aligning agent, a retardation film was prepared in the same manner as in Example 1.

<비교예 1><Comparative Example 1>

조제예 1에서 조제한 액정배향제(B-1)를 기판으로서의 TAC필름 상에 바코터를 이용하여 Wet막두께 4μm로 도포하였다. 열순환식 오븐 내에서 130℃에서 2분간의 가열건조를 행하고, 필름 상에 경화막을 형성하였다. 이어서, 이 경화막 표면에 313nm의 직선편광을 10mJ/cm2의 노광량으로 수직으로 조사하여, 액정배향막을 형성하였다. 수평배향용 중합성 액정용액LC-1을, 바코터를 이용하여 상기 액정배향막 상에 Wet막두께 34μm로 도포하였다. 이어서, 오븐 내에서 120℃에서 2분간의 가열건조를 행한 후, 질소하, 365nm의 비편광을 300mJ/cm2의 노광량으로 수직으로 조사함으로써 중합성 액정을 경화시켜, 위상차필름을 제작하였다.The liquid crystal aligning agent (B-1) prepared in Preparation Example 1 was applied on a TAC film as a substrate to a wet film thickness of 4 μm using a bar coater. Heat-drying was performed at 130 degreeC for 2 minute(s) in a thermal circulation type oven, and the cured film was formed on the film. Next, 313 nm linearly polarized light was vertically irradiated to the surface of this cured film with the exposure amount of 10 mJ/cm< 2 >, and the liquid crystal aligning film was formed. A polymerizable liquid crystal solution LC-1 for horizontal alignment was applied to the liquid crystal alignment layer with a wet film thickness of 34 μm using a bar coater. Then, after heating and drying at 120 ° C. for 2 minutes in an oven, under nitrogen, by irradiating a non-polarized light of 365 nm vertically at an exposure amount of 300 mJ/cm 2 to cure the polymerizable liquid crystal, a retardation film was produced.

<비교예 2><Comparative Example 2>

액정배향제로서 (B-1)을 이용하고, 비교예 1과 동일하게 조작하여, 위상차필름을 제작하였다.(B-1) was used as a liquid crystal aligning agent, and was operated in the same manner as in Comparative Example 1 to prepare a retardation film.

상기에서 제작한 각 위상차필름에 대하여, 하기 방법에 의해 평가를 행하였다. 그 평가결과를 표 2에 나타낸다.Each of the retardation films produced above was evaluated by the following method. Table 2 shows the evaluation results.

<배향성의 평가><Evaluation of orientation>

제작한 기판 상의 위상차필름을 한쌍의 편광판으로 끼우고, 육안에 의해 크로스니콜하에서의 위상차특성의 발현상황을 관찰하였다. 위상차가 결함없이 발현되고 있는 것을 ○, 위상차가 발현되고 있지 않은 것을 ×로 하여 「배향성」의 란에 기재하였다.The retardation film on the produced substrate was sandwiched by a pair of polarizing plates, and the state of expression of the retardation characteristics under cross nicol was observed visually. It described in the column of "orientation property" as (circle) the thing in which the phase difference was expressed without defect, and the thing in which the phase difference was not expressed was x.

<TAC보호성><TAC protection>

작성한 TAC필름을 포함하는 위상차필름이 컬하고 있지 않은 것을 ○, 컬하고 있는 것을 ×로 하여 「보호성」의 란에 기재하였다.When the retardation film containing the prepared TAC film was not curled, it was denoted by ○, and curled ones were denoted by ×, and it was described in the “Protection” column.

[표 2][Table 2]

Figure pct00017
Figure pct00017

표 2의 결과로부터, (C)성분으로서 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합한 폴리머를 사용함으로써, NMP를 포함하는 액정용액에 대한 배향성을 얻을 수 있음과 함께, NMP에 의한 TAC필름에 대한 데미지도 보호할 수 있음이 명백하다.From the results of Table 2, by using a polymer obtained by polymerizing a monomer containing an N-hydroxyalkyl (meth)acrylamide compound as the component (C), the orientation with respect to the liquid crystal solution containing NMP can be obtained, It is clear that damage to the TAC film by NMP can also be protected.

산업상 이용가능성Industrial Applicability

본 발명에 의한 경화막 형성 조성물은, 액정표시소자의 액정배향막이나, 액정표시소자에 내부나 외부에 마련되는 광학이방성 필름을 형성하기 위한 배향재로서 매우 유용하며, 특히, 3D디스플레이의 패턴화 위상차재의 형성재료로서 호적하다. 나아가, 박막트랜지스터(TFT)형 액정표시소자나 유기EL소자 등의 각종 디스플레이에 있어서의 보호막, 평탄화막 및 절연막 등의 경화막을 형성하는 재료, 특히, TFT형 액정소자의 층간절연막, 컬러필터의 보호막 또는 유기EL소자의 절연막 등을 형성하는 재료로서 호적하다.The cured film-forming composition according to the present invention is very useful as an alignment material for forming a liquid crystal alignment film of a liquid crystal display device or an optically anisotropic film provided inside or outside a liquid crystal display device, in particular, patterning retardation of 3D display It is suitable as a material for forming ashes. Furthermore, materials for forming cured films such as protective films, flattening films and insulating films in various displays such as thin film transistor (TFT) liquid crystal display elements and organic EL elements, in particular, interlayer insulating films of TFT-type liquid crystal elements, protective films of color filters Alternatively, it is suitable as a material for forming an insulating film or the like of an organic EL device.

Claims (11)

(A)광배향성기와, 하이드록시기, 카르복실기 및 아미노기로 이루어지는 군으로부터 선택되는 1개의 치환기를 갖는 화합물,
(B)적어도 N-알콕시메틸(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머, 그리고
(C)적어도 N-하이드록시알킬(메트)아크릴아미드 화합물을 포함하는 모노머를 중합시켜 이루어지는 폴리머를 함유하는 것을 특징으로 하는 경화막 형성 조성물.
(A) a compound having a photo-alignment group and one substituent selected from the group consisting of a hydroxyl group, a carboxyl group and an amino group;
(B) a polymer formed by polymerizing a monomer containing at least an N-alkoxymethyl (meth)acrylamide compound, and
(C) The cured film formation composition characterized by containing the polymer formed by polymerizing the monomer containing at least N-hydroxyalkyl (meth)acrylamide compound.
제1항에 있어서,
(A)성분의 광배향성기가 광이량화 또는 광이성화하는 구조의 관능기인 것을 특징으로 하는, 경화막 형성 조성물.
The method of claim 1,
(A) The photo-alignment group of component is a functional group of the structure to photodimerize or photoisomerize, The cured film formation composition characterized by the above-mentioned.
제1항 또는 제2항에 있어서,
(A)성분의 광배향성기가 신나모일기인 것을 특징으로 하는, 경화막 형성 조성물.
3. The method of claim 1 or 2,
(A) Photo-alignment group of component is cinnamoyl group, The cured film formation composition characterized by the above-mentioned.
제1항 또는 제2항에 있어서,
(A)성분의 광배향성기가 아조벤젠구조의 기인 것을 특징으로 하는, 경화막 형성 조성물.
3. The method of claim 1 or 2,
(A) Photo-alignment group of component is group of azobenzene structure, The cured film formation composition characterized by the above-mentioned.
제1항 내지 제4항 중 어느 한 항에 있어서,
(D)성분으로서, 가교촉매를 추가로 함유하는 것을 특징으로 하는, 경화막 형성 조성물.
5. The method according to any one of claims 1 to 4,
(D) As a component, it further contains a crosslinking catalyst, The cured film formation composition characterized by the above-mentioned.
제1항 내지 제5항 중 어느 한 항에 있어서,
(E)성분으로서, 밀착향상성분을 추가로 함유하는 것을 특징으로 하는, 경화막 형성 조성물.
6. The method according to any one of claims 1 to 5,
(E) As a component, it further contains a close_contact|adherence improving component, The cured film formation composition characterized by the above-mentioned.
제1항 내지 제6항 중 어느 한 항에 있어서,
(A)성분의 100질량부에 기초하여, (B)성분과 (C)성분의 합계량이 100 내지 3000질량부인 것을 특징으로 하는, 경화막 형성 조성물.
7. The method according to any one of claims 1 to 6,
(A) Based on 100 mass parts of component, the total amount of (B)component and (C)component is 100-3000 mass parts, The cured film formation composition characterized by the above-mentioned.
제1항 내지 제7항 중 어느 한 항에 있어서,
(B)성분과 (C)성분의 질량비가 1:99 내지 99:1인 것을 특징으로 하는, 경화막 형성 조성물.
8. The method according to any one of claims 1 to 7,
(B) Mass ratio of component and (C)component is 1:99-99:1, The cured film formation composition characterized by the above-mentioned.
제5항 내지 제8항 중 어느 한 항에 있어서,
(B)성분과 (C)성분의 합계량 100질량부에 기초하여, 0.01질량부 내지 10질량부의 (D)성분을 함유하는, 경화막 형성 조성물.
9. The method according to any one of claims 5 to 8,
(B) The cured film formation composition containing 0.01 mass parts - 10 mass parts (D)component based on 100 mass parts of total amounts of a component and (C)component.
제1항 내지 제9항 중 어느 한 항에 기재된 경화막 형성 조성물을 이용하여 얻어지는 것을 특징으로 하는 배향재.It is obtained using the cured film formation composition in any one of Claims 1-9, The orientation material characterized by the above-mentioned. 제1항 내지 제9항 중 어느 한 항에 기재된 경화막 형성 조성물로부터 얻어지는 경화막을 사용하여 형성되는 것을 특징으로 하는 위상차재.It is formed using the cured film obtained from the cured film formation composition in any one of Claims 1-9, The retardation material characterized by the above-mentioned.
KR1020217038911A 2019-05-27 2020-05-26 Cured film forming composition, alignment material and retardation material KR20220012859A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019098701 2019-05-27
JPJP-P-2019-098701 2019-05-27
PCT/JP2020/020754 WO2020241642A1 (en) 2019-05-27 2020-05-26 Cured film formation composition, alignment member, and retardation member

Publications (1)

Publication Number Publication Date
KR20220012859A true KR20220012859A (en) 2022-02-04

Family

ID=73552230

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217038911A KR20220012859A (en) 2019-05-27 2020-05-26 Cured film forming composition, alignment material and retardation material

Country Status (5)

Country Link
JP (1) JPWO2020241642A1 (en)
KR (1) KR20220012859A (en)
CN (1) CN113874470A (en)
TW (1) TW202104469A (en)
WO (1) WO2020241642A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS611342B2 (en) 1979-06-13 1986-01-16 Toppan Printing Co Ltd
JPH1068816A (en) 1996-08-29 1998-03-10 Sharp Corp Phase difference plate and circularly polarizing plate
JP2001517719A (en) 1997-09-25 2001-10-09 ロリク アーゲー Photocrosslinkable polyimide
JP2005049865A (en) 2003-07-17 2005-02-24 Arisawa Mfg Co Ltd Manufacturing method of optical phase difference element
JP4207430B2 (en) 2002-01-31 2009-01-14 Jsr株式会社 Liquid crystal aligning agent, method for forming liquid crystal aligning film, and liquid crystal display element
JP2009058584A (en) 2007-08-30 2009-03-19 Jsr Corp Liquid crystal aligning agent and method of forming liquid crystal alignment layer
JP2009179563A (en) 2008-01-29 2009-08-13 Fujifilm Corp Compound, liquid crystal composition and anisotropic material
US8119026B2 (en) 2007-03-30 2012-02-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Birefringent layer with negative optical dispersion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102042434B1 (en) * 2012-07-12 2019-11-08 닛산 가가쿠 가부시키가이샤 Composition for forming cured film, alignment material, and phase difference material
JP5974784B2 (en) * 2012-09-28 2016-08-23 Jnc株式会社 Inkjet ink
WO2015056741A1 (en) * 2013-10-17 2015-04-23 日産化学工業株式会社 Composition for forming cured film, alignment material, and retardation material
CN105980917B (en) * 2014-02-13 2019-08-23 大日本印刷株式会社 Heat-curable composition, oriented layer with light orientation, the substrate with oriented layer, phase plate and device
JP6754097B2 (en) * 2014-02-28 2020-09-09 日産化学株式会社 Resin composition for forming retardation material, alignment material and retardation material
WO2016002722A1 (en) * 2014-06-30 2016-01-07 日産化学工業株式会社 Alignment material, phase-difference material, and cured film–forming composition
WO2018173727A1 (en) * 2017-03-24 2018-09-27 富士フイルム株式会社 Optically alignable copolymer, optical alignment film, and optical layered body
JP2019008170A (en) * 2017-06-26 2019-01-17 Dic株式会社 Polymer for liquid crystal alignment film, liquid crystal alignment film, liquid crystal display element, liquid crystal display, optical anisotropic material, optical anisotropic film and optical device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS611342B2 (en) 1979-06-13 1986-01-16 Toppan Printing Co Ltd
JPH1068816A (en) 1996-08-29 1998-03-10 Sharp Corp Phase difference plate and circularly polarizing plate
JP2001517719A (en) 1997-09-25 2001-10-09 ロリク アーゲー Photocrosslinkable polyimide
JP4207430B2 (en) 2002-01-31 2009-01-14 Jsr株式会社 Liquid crystal aligning agent, method for forming liquid crystal aligning film, and liquid crystal display element
JP2005049865A (en) 2003-07-17 2005-02-24 Arisawa Mfg Co Ltd Manufacturing method of optical phase difference element
US8119026B2 (en) 2007-03-30 2012-02-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Birefringent layer with negative optical dispersion
JP2009058584A (en) 2007-08-30 2009-03-19 Jsr Corp Liquid crystal aligning agent and method of forming liquid crystal alignment layer
JP2009179563A (en) 2008-01-29 2009-08-13 Fujifilm Corp Compound, liquid crystal composition and anisotropic material

Also Published As

Publication number Publication date
JPWO2020241642A1 (en) 2020-12-03
WO2020241642A1 (en) 2020-12-03
CN113874470A (en) 2021-12-31
TW202104469A (en) 2021-02-01

Similar Documents

Publication Publication Date Title
TWI638836B (en) Thermosetting composition having photoalignment properties, alignment layer, substrate with alignment layer, retardation plate, and device
TWI608047B (en) Film formed in cured coating, alignment material and retardation material
TWI640548B (en) Thermosetting composition having photoalignment properties, alignment layer, substrate with alignment layer, retardation plate, and device
JP6823295B2 (en) Polymers containing repeating units with N-alkoxymethyl groups and repeating units with side chains containing polymerizable C = C double bonds
KR20120094460A (en) Composition for forming thermoset film having photo alignment properties
TW201116570A (en) Thermoset film forming composition having photo-alignment
KR102207515B1 (en) Thermosetting composition having photo-alignment properties, alignment layer, substrate with alignment layer, retardation plate and device
JP7260853B2 (en) Cured film-forming composition, alignment material and retardation material
WO2015019962A1 (en) Cured film-forming composition, alignment material, and phase difference material
TW201946941A (en) Cured film-forming composition, alignment material and retardation material
CN107532006B (en) Thermosetting resin composition and vertically aligned retardation film
KR20220012859A (en) Cured film forming composition, alignment material and retardation material
JP7472792B2 (en) Method for manufacturing liquid crystal alignment film, liquid crystal alignment film, and liquid crystal display element
JP2015152743A (en) Thermosetting composition having photo-aligning property, alignment layer, substrate with alignment layer, retardation plate, and device
JP5668881B1 (en) Thermosetting composition having photo-alignment, alignment layer, substrate with alignment layer, retardation plate and device
JP5626492B1 (en) Thermosetting composition having photo-alignment, alignment layer, substrate with alignment layer, retardation plate, and device
WO2023204280A1 (en) Cured film-forming composition, alignment material, and retardation material
TW202146566A (en) Cured film-forming composition, alignment material, and phase difference material